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2.  
ABSTRACT   
Background: The first 1,000 days of life are a unique period for the brain 
architecture. The development of perceptual, sensorimotor, social and language 
systems depend crucially on environmental stimulation. Multiple factors influence 
the acquisition of competencies, including health, nutrition, security and safety, 
responsive caregiving, and early learning. All are necessary for nurturing care and 
evolve through bi-directional interactions.   
Following children from born since adulthood researchers can identify individual 
trajectories through the different stages of growth that develop in function of the 
social and the historical context.   
Aim: The thesis aims to describe the development and running of a national birth 
cohort aiming to understand how the influences of environmental and nurture 
factors, that include also the social context, can affect child health.   
Methods: We performed an extensive review aiming for the identification of all the European 
Birth Cohorts focusing on those that started data collection at birth.  
All the information gathered from this review has been essential to defining and 
running NASCITA (NAscere e CREscere in ITAlia) a national birth cohort officially 
started on the 1st of April 2019. In this thesis, I will present the protocol, the 
management and the organization of this birth cohort and some preliminary results.  
Results:   
The enrollment of newborns began on April 1st, 2019. After six months from the 
start, the number of participating pediatricians was 160 and the number of children 
enrolled 2264. Most of the mothers (84%) were born in Italy and had a healthy 
pregnancy. The anthropometric measures of the newborns were showing an 
 
3.  
average of 3792 grams at birth and 59% of them were also breastfed at 6 months. 
Discussion: The only way to understand the epidemiology of diseases and to address 
related needs is through large epidemiological studies. In NASCITA we aim to 
perform an in-depth study of child development and health and the impact on them 






















I would first of all thank Dr Maurizio Bonati for his guidance and for gave me the 
possibility to achieve this important personal objective. I would also like to thank 
Prof Imti Choonara for his trust in me and the help over these years.   
A special thanks to Chiara Pandolfini for her daily assistance and for the knowledge 
she passed on to me. Thanks to Antonio Clavenna for his professionalism and 
expertise.   
Thanks to Daniela Miglio and Massimo Cartabia for the valuable work done over 
these years and in these last weeks. Thanks to Maria Grazia Calati and Michele 
Zanetti for the daily assistance in the NASCITA project. Thanks also to all the other 
components of the staff that help me in these years.   
Last but not least I would also like to thank my family. My children, Beatrice and 
Edoardo, that are the essence of my life and that gave me every day a reason to do, 
and to be, better. Thanks to my husband that supports me all over the PhD period 
and in the professional decisions of my life. Thanks to my mother and father for the 
help over these years. Without all of them, I could never have reached this 







    
 
5.  
                                                                                                                     Pag.  
ABSTRACT           2  
Acknowledgement         4  
TABLE OF CONTENTS        5  
LIST OF TABLES AND FIGURES        8  
LIST OF ABBREVIATIONS         10  
I.  INTRODUCTION   
11 A.  The first thousand days of life and the child health   11  
 A.1  Nurturing care and Social Determinant that support   
 children’s developmental health  13  
 A.2  Non-communicable diseases  16  
 B.  The Italian health system framework  17  
 B.1  Databases for health care research  18  
 B.2  Reimbursed prescription database  19  
 B.3  Hospital discharge form database  19  
 B.4  Specialist visits databases  20  
 B.5  CEDAP: Certificate of Delivery Assistance  21  
C  Strength and limitations of these databases and available data 22 
 D  Organization of pediatric’s care and Health visits                            23  
 D.1  Scientific research in pediatric setting  24  
 E  The evidence based medicine                                                              25   
 E.1  Cohort studies  26  
 E.1.1 Statistical analysis in the cohort studies  29  
 E.2  Data collection methods   32  
F.  Strength and limitations of longitudinal cohort    33 
 G.  Gap of knowledge        35  
II.  AIMS          36 
    
 III.  STEPS (Methods)  38  
 A.  Step 1: An inventory of the existing European Birth Cohorts  38  
 A.1  Background  38  
 
6.  
 A.2  Material and methods  40  
 A.2.1 Search strategy  40  
 A.2.2 Data extraction  41  
 A.3  Results  43  
 A.3.1 Identification of the Cohorts  44  
 A.3.2 The European Panorama  50  
 A.3.3 The 45 Cohorts Starting Recruitment at Birth  50  
 A.4  Discussion  57  
 A.5  Conclusions  63  
 A.6  A view on major international longitudinal studies and initiatives 64  
 B.  Step 2: NASCITA (NAscere e creSCere in ITAlia) a new birth cohort    
 B.1  The protocol  71  
 B.1.1 Background: The nurturing care  71  
 B.1.2 The Italian context  72  
 B.1.3 Hypothesis and significance  73  
 B.1.4 Aims  74  
 B.2  Methods  75  
 B.2.1 Study area and setting  76  
 B.2.2 Study design  77  
 B.2.3 Participants characteristics  78  
 B.2.4 Inclusion and exclusion criteria  78  
 B.2.5 Pilot phase  79  
 B.2.6 Recruitment  79  
 B.2.7 Study population size  80 
 B.3  Training and tutorial activities  82  
 B.4  Data collection  83  
 B.4.1 Baseline data  84  
 B.4.2 Follow-up and outcomes  85 
 B.4.3 Statistical analysis  88  
 B.5  Organization framework  89  
 B.6  Ethics and dissemination  90  
 
7.  
 B.7  Application of study results  91  
 B.8  Strengths and limitations of this study  92 
 C.  Step 3: Engagement and Dissemination activities of NASCITA  
 project  93  
 C.1  The Web portal  94 
 C.2  Family pediatricians area: The Electronic case report form  97 
 C.3  Materials produced  99 
 D.  Step 4: Preliminary Data from NASCITA  106  
 D.1  Family pediatricians’ enrolment  106  
 D.2  Newborns enrolment  110 
 D.3  Preliminary data on family  110 
 D.4  Preliminary data on pregnancy and labour  111  
D.5 Preliminary data on some data collected during the first  
6 months of life                 111 
IV.  DISCUSSION                   112  
A.  Future directions                  119 
 B.  Strengths and weakness                             121  
V.  CONCLUSION                   122  
VI.  BIBLIOGRAPHY                                          125  
VII.  APPENDIX                  149  
Apprendix A. Embase and PubMed search strategies         149 
Appendix B. Ethics application             152 
Appendix C. Data collected in the first visit                                    164  
Appendix D. Data collected in the second visit                           180  
   Appendix E. Data collected in the third visit     186 
Appendix F. Newsletter      193  
                                                      






    
LIST OF TABLES AND FIGURES   
     Pag.  
 Figure 1.  Synapse formation in the developing brain  12  
 Figure 2.  Sensitive periods in early brain development  13  
 Figure 3.  The pyramid of evidence  25   
 Figure 4.  Literature selection from the two databases: Medline and Embase 
   43  
 Figure 5.  Selection of articles and number of related cohort  44 
 Table 1.  List of the 45 birth cohort (Details)  47 
 Table 2.  The 45 European birth cohorts analysed  51  
 Figure 6.  Location of the countries participating in the 45 birth cohorts  53  
 Figure 7.  Cohorts’ enrolment period, follow-up status (Ongoing/Closed),  
 and duration (years)  54  
 Figure 8.  Frequency of scientific areas addressed by the cohorts   56  
 Figure 9.  Map of the world showing the location of the preconception,  
prenatal, and birth cohorts identified                                     65  
 
     Figure 10. Location of the African birth cohorts                               65  
Figure 11. Percent of birth cohort studies conducted by province and territory 
in Canada                                                                                         66 
Figure 12. Location of the Asian birth cohorts                                                    69  
     Figure 13. GLORI 2.0 - Currently Studies country                                                69  
Figure 14. Homepage of Research Advancement through Cohort Cataloguing 
website                                                                                        70  
Figure 15. Geographical distribution of NASCITA birth cohort                        76  
 Table 3.  National prevalence of certain health characteristics of the Italian  
children and the expected cases for different enrrolling scenarios 
in the NASCITA cohort study                                                 82  
Figure 16. Timeline of data collection, follow up, and milestones in the  
 
9.  
 NASCITA Study  84  
 Table 4.  Overview of outcome measures collected by follow up stage  86  
 Figure 17. Sections of the web portal  95  
 Figure 18. NASCITA in ClinicalTrials.gov  97  
 Figure 19. eCRF screenshots  98  
 Figure 20. Leaflets  100 
 Figure 21. Conference leaflets  102  
 Figure 22. Conference posters and press  103  
  Figure 23. Spread of information through social network (Twitter and  
 Facebook)  105  
Figure 24. Localisation North Center and South Italy of the ACP members 
   106  
 Figure 25. Family pediatrician’s enrollment strategy  109  
 Figure 26. Number of enrolled newborns  110  
 Figure 27. Childhood development: Interconnections  112 
 
10.  
     LIST OF ABBREVIATIONS  
ACP: Associazione Culturale Pediatri  
CRF: Case Report Form;   
DOHaD: Developmental Origins of Health and Disease eCRF: 
Electronic Case Report Form  
FP: Family pediatrician   
GP: general practitioner   
GBD: Global Burden of Diseases  
ICD: international classifications of diseases  
LHU: Local Health Unit  
MMR: measles-mumps-rubella   
NASCITA: NAscere e creSCere in ITAlia  
NCD: non-communicable diseases  
NHS: National Health System  
NIP: national immunisation plan  
OR: odds ratio  
 RCT: Randomized Controlled Trial    
RR: The relative risk  
WHO: World Health Organization  
  







 I.  INTRODUCTION  
  
 A.  The first thousand days of life and the child's health.  
The time between conception and second birthday, well known as the first 1,000 
days of life, is a unique period of opportunity and vulnerability. Studies conducted 
over the past twenty years have shown how the architecture of the brain depends 
on the mutual influences of genetics, environment, and experiences.   
Brains are built over time and the basic architecture is constructed through an 
ongoing process that begins before birth and continues into adulthood. Early 
experiences affect the quality of that architecture by establishing either a robust or 
a fragile foundation for the learning, health and behaviour that follow. According to 
the well-evidenced Developmental Origins of Health and Disease concept (originally 
the ‘Barker hypothesis’), a disadvantage in fetal life and early childhood influences 
health in adulthood [Barker 2004; Barker et al. 1989].  
In the first few years of life, 700 new neural connections (called synapses) 
are formed every second [Bourgeois 1997; Singer 1995]. After this period of rapid 
proliferation, these connections are reduced through a process called pruning, so 
that brain circuits become more efficient. Sensory pathways, like those for basic 
vision and hearing, are the first to develop followed by early language skills and later 
by higher cognitive functions (Figure 1 and Figure 2) [Nelson et al 2000; National 






    
 Figure 1.  Synapse formation in the developing brain  
  
  
Early environments and experiences have an exceptionally strong influence on brain 
architecture. Developmental changes may occur in different “critical periods” of the 
prenatal (germinal, embryonic and fetal) and of the post-natal development. 
Complex epigenetic mechanisms are activated, regulating and programming the 
expression of our gene pool in response to several influences, mainly: maternal 
factors (e.g. physical and psychological health, lifestyle) and environmental factors 
[Barker et al. 1986; Jaakkola et al. 2004].  
The period of exceptional sensitivity to the effects of environment and experience is 
called a “sensitive period” for that circuit. This sensitive period is a constrained 
window of time when the environment most impacts brain function via experience-
expectant mechanisms with a residual plasticity after the period ends such that 
experiences may continue to affect brain function [Nelson et al. 2020]. Some 
examples of behavioral capacities that are affected by sensitive periods of 
underlying circuitry include vision, hearing, and language (Figure 2) [National 
Scientific Council on the Developing Child, 2007].  









A.1 Nurturing care and Social Determinant that support children’s developmental health  
  
The nervous system is especially sensitive to certain stimuli and the development of 
certain perceptual, sensorimotor, social and language systems depends crucially on 
environmental stimulation [Fox et al. 2010] . 
Children’s early development is characterised by sensitive periods for development 
related to maturation and genetic–environmental interactions, the effect of 
interventions varies based on sensitive periods related to specific experiences or 
environmental conditions. [Black et al. 2017; Wachs et al 2014]. In this context 
resaerchers demonstrate how the timing of nutrient provision or deficiency 
determines how the structure develops and ultimately how it functions. A given 
nutrient deficit at one age may result in quite different developmental effects than 
the same nutrient deficit at another age. These findings imply that critical/sensitive 
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windows exist for many of these systems and that these windows are tightly linked 
to periods of rapid regional brain growth and differentiation. [Wachs et al 2014] 
Multiple factors interact with each other and can be mutually reinforcing through 
the process of development and influence the acquisition of competencies. 
Nurturing care is characterised by good health, adequate nutrition, safety and 
security, responsive caregiving and opportunities for early learning and occur 
through bidirectional interactions, initiated by both children and caregivers, and 
sustained by their environments. [Black et al 2017] It is also linked to a home 
environment that is sensitive to children’s health and nutritional needs, responsive, 
emotionally supportive, and developmentally stimulating and appropriate, with 
opportunities for play and exploration and protection from adversities. Positive 
associations between nurturing care and children’s health, growth, and 
development have been demonstrated worldwide, supported by neuroscientific 
evidence that nurturing care during early childhood attenuates the detrimental 
effects of low socioeconomic status on brain development [Black et al. 2017; Britto 
et al. 2017].  
Among the environmental stimuli that influences children healthy developments 
and neurodevelopment there are several factors: socioeconomic, interpersonal 
and/or family, and nutritional [Bick et al. 2016].  
Researchers show that the family (defined as any group of people who eat and 
participate in other daily, home-based activities together) quality of care, activities 
and socialization, play an important role since is the primary environmental 
influence on children’s development [Cornish et al. 2005]. The most salient features 
of the family are its social and economic resources. Social resources include 
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parenting skills and education, cultural practices and approaches, intra-familial 
relations, and the health status of family members [Houweling et al. 2005].  
Stable, responsive, nurturing relationships and rich learning experiences in the 
earliest years provide lifelong benefits for learning, behavior and both physical and 
mental health. In contrast, research on the biology of stress in early childhood 
shows how chronic stress caused by major adversity, such as extreme poverty can 
weaken developing brain architecture and permanently set the body’s stress 
response system on high alert, thereby increasing the risk for a range of chronic 
diseases [National Scientific Council on the Developing Child, 2005; Darling et al. 
2020].  
Lancet series in 2013 added support for a focus on the first 1000 days as previously 
called in the 2008 Maternal and Child Undernutrition Lancet [Bhutta et al. 2008] The 
subsequent 2013 Lancet Series on Maternal and Child Nutrition further 
demonstrated early undernutrition as a serious hidden cause of child mortality and 
increased risk of adult chronic diseases. [Bhutta et al. 2013] On the contrary, 
evidence has continued to mount that in high-income countries, nutrition in the first 
1000 days (including maternal nutrition, obesity during pregnancy, breastfeeding 
and early diet) has a powerful impact on later risk of obesity (Hu et al. 2020) 
Breastfeeding is important for infants as it helps protect against infections [Renfrew 
et al. 2012]. It is also thought that breastfeeding contributes to cognitive 
development, reduced risk of developing obesity and Type 2 diabetes [Victora et al. 




It is important that weight in early childhood is recorded, monitored and maintained 
at a healthy level since overweight children are likely to present other health and 
wellbeing problems and are likely to become overweight adults. Since children aged  
<4 years have frequent contact with their general practitioner (GP) or family 
pediatrician (FP), primary care is perfectly positioned to collect this early childhood 
weight data and deliver effective early intervention. Integration of electronic growth 
charts and centile calculators into GP health systems would support this commitment 
and benefit both health professionals and the children they care for.  
  
 A.2  Non-communicable diseases  
Several studies have been conducted to understand which influential factors 
occurring during the early stage of development affect the risk of going 
encountering non-communicable diseases, often much later in life. The 
“developmental origins of health and disease” (DOHaD) is a concept that has 
emerged over the past 50 years, linking the state of health and risk from the disease 
in later childhood and adult life with the environmental conditions of the early life.  
The first 1,000 days of life, thus, represents the ideal target of any primary 
prevention program for non-communicable disease. Policies, plans and services for 
the prevention and control of noncommunicable diseases need to take account of 
health and social needs at all stages of the life-course, starting with maternal 
health, including preconception, antenatal and postnatal care, maternal nutrition 
and reducing environmental exposures to risk factors, and continuing through 
proper infant feeding practices, including promotion of breastfeeding and health 
promotion for children, adolescents and youth followed by promotion of a healthy 
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Non-communicable diseases (NCD), represent today the most important health 
problem in both advanced and developing countries. [GBD 2017] This epidemic 
situation, probably linked to the profound lifestyle changes, has serious implications 
on the quality of life of the population but also an equally important socioeconomic 
impact, that is often underestimated.   
Health promotion and prevention of NCDs in the early ages of life must necessarily 
be based on a wider intervention that has the aim of promoting a healthy lifestyle 
throughout the reproductive age, therefore right from school. Generally, on the 
adoption of healthy lifestyles and essentially on a more balanced diet, on the 
promotion of physical activity and the promotion of an ecosystem free of pollutants. 
Improving family health requires addressing the social determinants of health and 
inequities (ex: infant mortality reduction comes from improved women education).  
  
 B.  The Italian health system framework  
Italian healthcare is provided free or at a nominal charge through a network of 20 
Regions and 101 Local Health Units (LHUs). Every Italian resident is registered with a 
family (pediatric or general) practitioner. Children are assigned to a FP until they are 
6 years old; afterward, the parents can choose to register a child with a GP.  
Pharmaceutical prescriptions that are issued by the FP or by the GP, In Italy, 
are collected in a national formulary that is available for researchers and in which 
 
18.  
drugs are categorised into three classes: class A includes essential drugs that 
patients do not have to pay for, class C contains drugs not covered by the National 
Health System (NHS), and class H contains drugs administered only to inpatients that 
are fully reimbursed. Italian outpatients receive class A prescriptions from FPs, GPs, 
or other specialists and then get medications free of charge from retail pharmacies. 
Outpatients receiving prescriptions in community pharmacies and get the medicines 
free of charge through  
GP prescriptions. Each local pharmacy provides these prescriptions to the Regional  
Health Authority to get reimbursed.  
  
  
 B.1 Databases for healthcare research   
While administrative data are not designed for research, have limitations, are often 
difficult to access, and the linkage required between certain databases may be 
unfeasible, yet they retain a great research potential. The Administrative Data 
Taskforce identified the following items of value associated with the use of 
administrative [Connelly et al. 2016].  
• The data already exists. There are no additional data collection costs associated with 
research use;  
• The data are typically large datasets, permitting more detailed research to be 
undertaken than would otherwise be the case;  
• The data records a process, which can be documented and understood;  




• Linkage to other data sources (e.g. surveys) can enhance these resources. Additionally, 
health databases can provide data on diagnosed diseases through hospital admission 
and surgical procedures codes. The information on prescribed drugs, with appropriate 
techniques and integrations, can be used to estimate the prevalence of certain 
diseases, also in the outpatients.  
The Italian healthcare system can exploit with small differences between regions, three 
different databases. 
 
 B.2 Reimbursed prescription database  
The database contains reimbursable prescriptions (class A) routinely acquired for 
administrative and reimbursement reasons. The database stores all community (i.e. 
outside hospital) prescriptions issued to individuals living in a specific region. Within 
this system, a unique patient code prevents double counting of individuals who have 
been prescribed drugs by more than one physician. Each prescription is associated 
with a unique code identifying the medicine prescribed (including dosage and 
formulation). Other information available is: the prescription date, the number of 
boxes prescribed, and the prescriber and his/her characteristics.  
  
 B.3  Hospital discharge form database  
Besides prescription data, this database contains the hospital admissions of patients 
classified according to the ICD-9 system (hiips://www.cdc.gov/nchs /icd/index.htm) 
[Centers for Disease Control and Prevention, 2020]. The relevant information 
available is concerning the patients’ vital statistics (age, sex, and address of 
residence); characteristics of the hospital stay (institute, ward and unit, type of 
admission, length of stay, priority) and clinical characteristics (primary diagnosis, 
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other secondary diagnoses, diagnostic and therapeutic procedures, date of 
admission, discharge, or in-hospital death). Drugs administered during the hospital 
stay are not included in this database.   
 
B.4   Specialist visits database  
Information about the outpatient specialist visits, in particular: prescriptions for 
diagnostic tests, specialist visits, and rehabilitation performed in outpatient 
ambulatories are recorded for each resident patient.  
Since these three databases share the same unique patient identifier - through the 
Patient Record Database (which contains each patient’s vital statistics) - 
prescriptions, hospital admissions and specialist visits can be linked  
straightforwardly.  
The availability of these data depends on single projects. For each project, a specific authorisation 
should be requested at competent authorities.  
For example, in our laboratory (Laboratory for Mother and Child Health) a 
pharmacoepidemiologic project called EPIFARM was running since 2003 in 
agreement with the Regional Health Ministry of the Lombardy Region [EPIFARM, 
2003]. The quality and accuracy of data are routinely checked and validated each 
year ensuring high standards. The anonymity of each patient is granted by a third 
party society, that is not involved in any way in the analyses of the data, and that 





 B.5  CEDAP: Certificate of Delivery Assistance   
Implemented by the Ministry of Health into law in 2001, the Certificate of Delivery 
Assistance, or CEDAP, is the national source for vital birth information. Information 
collected and added to the birth certificate includes basic data relating to births, 
stillbirths, and newborns with congenital malformations. The questionnaire included 
at the end of the document is divided into sections: the general personal data and 
socio-demographic characteristics of the parents; conditions of the pregnancy; 
circumstances of the delivery and the health of the newborn; the causes of stillbirth 
where applicable; and the presence of congenital malformations if present. There 
are also tables of the most common malformations and causes of stillbirths [Regione 
Lombardia, 2019].  




 C.  Strength and limitations of these databases and available data  
The main advantage of monitoring the prescriptions dispensed by all the physicians 
to an entire population in a specific region is that data are available for a long period 
and easily available for longitudinal research.  
Moreover, there is no bias for the exclusion of children with different familiar 
socioeconomic status, or concerning the prescription of more costly drugs, like is the 
case in other countries.  
The main limits related to the use of these health care databases are that over-the-
counter drugs, and drugs not reimbursed by the national health service, are not 
included. Other limitations are that the therapeutic indication is lacking and that it is 
not possible to know if the patient took the drug. Moreover, information concerning 
the socio-economic status or the educational level of the individuals is not available. 
To overcome this issue usually in some studies, average annual income at the area 
level was used as a proxy to the socio-economic status of individuals and families. 
Another way to overcome these limitations could be the design of a longitudinal 




D.  Organization of pediatric’s care and health visits   
The Italian Health System provides, thanks to the collaboration with the family 
pediatricians, for all children and adolescents a routine health check system called 
“Bilanci di salute” or "filter visits" with contents agreed and defined at the regional 
level occurring at pre-established times from the first month of life to 14 years old.  
They are guaranteed in the context of primary pediatric care and are a valid dynamic 
and prospective tool that accompanies the child's growth. Since the “filter visits” are 
based on specific protocols, are important in the early evaluation of some disorders 
(ex: neuropsychiatric disorders).. Through these visits, pediatricians have a unique 
opportunity to identify and address important social, developmental, behavioral, 
and health issues that could have significant and long-lasting effects on children’s 
lives as adults, early and intensive visits are important for early childhood 
development and unfavorable outcomes prevention. [Shah et al. 2016]  
According to the WHO definition: "Health is not only a state characterized by the 
absence of disease but by the achievement of a state of physical, mental and social 
well-being." In the context of primary pediatric care, In Italy, the Presidential Decree 
number 613/96 for the first time explicitly recognized the importance of prevention 
and health education thought the well-child visits guaranteed . 
 
In this context, the FP establishes a continuous and privileged contact with the 
family. In this particular setting disease prevention, health education and correct 
lifestyles, health improvement and patient empowerment activities can be 
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developed and implemented, which represent an added value to normal care 
activities for acute and chronic pathology.  
In recent years, social and cultural changes and rapid scientific-technological 
progress have changed the health needs of the pediatric population, in particular, 
we can observe: development of diseases resulting from poverty and foodstuffs (e.g. 
overweight and obesity); the increase of diseases linked to environmental factors 
etc…   
The main objectives of the “filter visits” are:  
• assess the child's health status to identify and prevent the appearance of secondary 
complications;  
• provide indications of health education, anticipating as far as possible the problems 
related to the natural history of the pathology responsible for disability;  
• implement specific prevention interventions;  
• understand the health needs and discomforts of the family, interacting closely with basic 
medicine and psycho-social services.  
 
D.1  Scientific research in the pediatric setting  
 
Since 2001 in Italy, as in the rest of Europe, was adopted the European Clinical Trials 
Directive (2001/20/CE) that simplified and harmonized the controlled clinical 
assessment in general and pediatric practice. Under the clinical governance, the FP’s 
daily work became an opportunity for the development and running of a scientific 
research. 
In particular the well-child care visits, also called “bilanci di salute” represents a 
unique opportunity for the collection of epidemiological data. In this context, they 
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are essential for identifying specific health problems and to identify any difference 
in the Italian setting, as well as useful for developing research in the field of primary 
care.  
A useful observation arises from previous experiences occurring in my laboratory, 
“Laboratorio per la salute materno infantile”, in collaboration with the family 
pediatricians, shows how, in the first year of the child's life, there is a high use of 
health resources (access to the emergency room, number of specialist visits) and a 
high prescription of drugs (antibiotics and not ..) with important differences 
between the north, center and southern Italy. (Bianchi et al 2013;  Putignano et al 
2019; Clavenna et al 2014; Piovani et al 2013)  
  
 E.  The evidence-based medicine   
In medical science, routinely collected data is a valuable resource for use in 
epidemiological studies [Vandenbroucke 2004] and is an important tool for 
evidence-based medicine. Evidence-based medicine has been described as ‘the 
conscientious, explicit and judicious use of current best evidence in making 
decisions about the care of individual patients [Sackett et al. 1996]. The first and 
earliest principle of evidence-based medicine indicated that not all evidence is the 
same but a hierarchy of evidence exists. Various versions of the evidence pyramid 
have been described, but all of them focused on showing weaker study designs in 
the bottom (basic science and case series), followed by case–control and cohort 
studies in the middle, then randomised controlled trials (RCTs), and at the very top, 




 Figure 3.  The pyramid of evidence  
  
  
The randomised controlled trial is the principal research design in the evaluation of 
medical interventions. However, aetiological hypotheses, for example, those 
relating common exposures to the occurrence of disease—cannot generally be 
tested in randomised experiments. Analyses of observational data also have a role in 
medical effectiveness research [Egger et al. 1998].  
  
    
 E.1  Cohort studies  
The most efficacious study design to detect possible correlation within several 
factors are longitudinal studies: Cohorts studies. In longitudinal studies, the word 
cohort describes a group of people who share a common experience or condition. 
Cohort studies are studies in which subsets of a defined population are identified. 
These groups may, or may not, be exposed to factors hypothesized to influence the 
probability of the occurrence of a particular disease or other outcomes. Cohorts are 
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defined populations that, as a whole, are followed in an attempt to determine 
distinguishing subgroup characteristics.  
Prospective birth cohort studies are amongst the strongest observational study 
designs. Birth cohorts are observational longitudinal studies that follow participants 
(parents and their children) from the intrauterine period, birth or shortly after, 
through childhood into adolescence and sometimes adulthood. The main 
advantages are that risk factors and health outcomes of subjects may be monitored 
continuously, or they may be assessed repeatedly at specified time intervals and the 
data permits researchers to calculate relative risks of individual or cumulative 
factors and gain insight into the aetiology of disease processes.  Therefore, as 
observational studies, they do not involve any experiments or any other 
interventions by researchers. The primary purpose of these studies is to identify and 
examine the relationship between suspected or known risk factors or exposures 
with the prevalence of disease as an outcome. This permits hypotheses about these 
risk factors, such as cigarette smoke exposure, to be tested by comparing the 
prevalence or incidence of disease in various groups that are identified as being at 
different levels of risk for disease.  
However, there are limitations of this study design. To obtain sufficient data, it is 
necessary to study a large number of individuals over an extended period. The 
prolonged period of follow-up involved in this study design accounts for the larger 
attrition rates associated with this study design. The loss to follow-up may result in 
incomplete data sets this limiting the statistical power of the study. This is why a 
large number of participants is required by researchers wishing to conduct research 
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using this study design. It also usually requires considerable logistical effort to 
coordinate recruitment and subsequent follow up of participants.  
Despite the efforts required to conduct these studies, to date, there have been 
several birth cohort studies that have demonstrated results that justify the effort 
required. Historical birth cohorts launched after the Second World War analysed the 
lives of thousands of babies from birth through life in staggering detail, from records 
of birth weights and ages of weaning to reading skills and employment in later life. 
Results from these studies firstly birth to analyse the educational and socioeconomic 
effects on child growth currently looking for the effect of aging. Or the Framingham 
Heart Study that began in 1948 and is now on its fourth generation of participants 
thanks to which much of the now-common knowledge concerning heart diseases, 
such as the effects of diet, exercise, and common medications such as aspirin, is 
based on this longitudinal study [Mahmood et al. 2013]. A detailed description of 
current and historical will be presented in the next chapter. Following children from 
birth into adulthood, and in some cases throughout all lives, researchers can identify 
individual trajectories towards the different stages of growth that change in function 




E.1.1 Statistical analysis for cohort studies   
Health indicators are commonly used to estimate population health. In a 
longitudinal study, subjects are followed over time with continuous or repeated 
monitoring of risk factors or health outcomes, or both. Most examine associations 
between exposure to known or suspected causes of disease and subsequent 
morbidity or mortality. The common definitions given assume that rates in an 
"exposed" population are being compared with those in "unexposed" people. The 
exposure might be to "risk factors" suspected of causing the disease (for example, 
being bottle-fed or owning a cat) or of protecting against it (for example, 
immunisation). (https://www.bmj.com/about-bmj/resources-
readers/publications/epidemiology-uninitiated/3-comparing-disease-rates) 
The relative risk (RR) that is usually calculated in this kind of study, defined the ratio 
of the disease rate in exposed persons to that in unexposed people and is the 
measure of association most often used. Closely related to relative risk is the odds 
ratio (OR), defined as the odds of disease in exposed persons divided by the odds of 
disease in unexposed persons. Most complex statistical analysis, like regression 
analysis, a set of statistical processes for estimating the relationships between a 
dependent variable (often called the 'outcome variable') and one or more 
independent variables (often called 'predictors', 'covariates', or 'features'), can be 
applied in function of the specific study protocol and the specific associations that 
should be investigated.  




 Central amongst these are:  
 (I) the linked nature of the data for an individual, despite separation in time;  
(II) the co-existence of fixed and dynamic variables;  
(III) potential for differences in time intervals between data instances;  
(IV) the likely presence of missing data.  
Whatever the study type, study planning and procedure, must always avoid the 
various forms of bias, such as systematic errors (for example, selection of study 
population) and confounding factors [Vandenbroucke 2004].  
It is defined as bias any systemic error (design, data collection, analysis or reporting 
of a study) in epidemiological study that results in incorrect estimation of the 
association between exposure and outcome. Investigators can introduce bias into a 
study as a result of the procedures for identifying and enrolling subjects or from the 
procedures for collecting or analysing information.  
Type of bias:  
• Selection bias: Selection bias can result when the selection of subjects into a 
study or their likelihood of being retained in the study, leads to a result that is 
different from what you would have gotten if you had enrolled the entire 
target population.  
This form of selection bias could be more common in a retrospective cohort 
study. Factors affecting the enrolment of subjects into a prospective cohort 
study would not be expected to introduce selection bias. The reason is that, in 
prospective cohort studies, subjects are enrolled before they have experienced 




• Information bias: The method of gathering information is inappropriate and 
yields systemic errors in the measurement of exposure or outcome. For 
example, the recall bias. When people interviewed with a particular outcome 
or exposure may remember events more clearly than others. Or the reporting 
bias, when participants can collaborate with researchers and give answers in 
the directions they perceive are of interest. Or loss to follow up. Those that 
are lost through follow-up or who withdrawn from the study may be different 
from those who are followed for the entire study.  
• Confounding: Confounding is one type of systematic error that can occur in 
epidemiologic studies. It is the distortion of the association between an 
exposure and health outcome by an extraneous, third variable called a 
confounder. It is a very important issue because if present, it can cause an 
over- or underestimate of the observed association between exposure and 
health outcome. The distortion introduced by a confounding factor can be 
large, and it can even change the apparent direction of an effect.  
Confounding should be of concern when:   
• Evaluating an exposure-health outcome association.  
• Quantifying the degree of association between an exposure and health 
outcome.  
• Multiple causal pathways may lead to the health outcome.  
The confounding is the only type of bias that could be controlled at different 
stages: during the study design or later in the analysis stage. To avoid the 
confounding bias during the study design is possible to apply:  
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• Restriction: subjects are restricted to only those possessing a narrow range of 
characteristics, to equalize important extraneous factors.   
• Matching: for each patient in one group there are one or more patients in the 
comparison group with the same characteristics, except for the factor of 
interest. (Es: matching done for age, sex, race, etc…)  
• Randomization: subjects of study are randomly selected to even out unknown 
confounders.  
The possible confounding could be avoided also later in the analysis stage applying:  
• Stratification: The process of separating a sample into several sub-sample 
according to specific criteria such as age group, socioeconomic status, etc.  
• Multivariate analysis: the statistical analysis of data collected on more than 
one variable (es: people age, weight, body fats…) [Smith & Phillips 1992; 
Hemkens et al. 2018].  
  
 E.2  Data collection methods  
Longitudinal research can utilize either data collected by a researcher from first-
hand sources (primary data), or data gathered from studies that have been run by 
other people or for other research (secondary data).  
For both the options: the most common data collection methods can include:  
• responses to survey questions;  
• direct clinical measurements such as height, weight that are carried out by trained 
personnel as part of a face-to-face interview;  
• clinical samples, for example, blood, hair or saliva;  
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• linking study results to administrative data from government records. (See the 
section on the Italian health system framework).  
Data should be collected using a structured form. First of all, it is important to 
ensure that all the Case Study Report (CRF) are optimally designed, and protocol-
driven. Besides the methods of data collection preferred, all the longitudinal studies 
need a structured and safe informatic data collection [Zanetti et al. 2019]. To 
structure data longitudinally, information on visits and contacts must be organized 
that, in turn, can be linked over time to individuals, a “patient log-list”. In European 
Nordic countries where there is a comprehensive registration of data for a high 
proportion or all of the population, government-administered patient registries may 
include hospital encounters, diagnoses and procedures, such as the Norwegian 
Patient Registry, the  
Danish National Patient Registry or the Swedish National Patient Register.  
  
 F.  Strength and limitations of longitudinal cohort  
Strength of longitudinal cohort include:  
• The ability to identify and relate events to particular exposures, and to further define 
these exposures with regards to presence, timing and chronicity;  
• Establishing sequence of events.  
• Following change over time in particular individuals within the cohort.  
• Excluding recall bias in participants, by collecting data prospectively and prior to 
knowledge of a possible subsequent event occurring.  
Disadvantages are implicit in the study design, particularly by virtue of this occurring over 
protracted time periods:   
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• Incomplete and interrupted follow-up of individuals, and attrition with loss to follow-
up over time.  
• Difficulty in the separation of the reciprocal impact of exposure and outcome, in view 
of the potentiation of one by the other; and particularly wherein the induction period 
between exposure and occurrence is prolonged.  
• The potential for inaccuracy in conclusion if adopting statistical techniques that fail to 
account for the intra-individual correlation of measures.  




 G.  Gap of knowledge  
Research has shown that there are key building blocks that serve as a foundation of 
children’s developmental health. These determinants may be considered under 
three general themes: Care, Support and Opportunity. In most industrialized 
societies, is highly dependent on two enabling conditions: Family time and resources 
(that is, time to care personally for children, adequate income/financial resources 
and educational skills, knowledge and access to information); and universally 
accessible community services such as high-quality education, care, health programs 
and services. It is in this context that we decide to develop this thesis with the aim 
to understand how the influences of environmental factors and nurture, that 
include also the social context, can affect the process of child development and 
health, and its changes across time.  
To address these questions, the most suitable and complete methodology designs 
are the longitudinal studies and the prospective birth cohort studies.  
In the first part of my thesis, I concentrate my efforts on the identification of all the 
European Birth Cohort and perform an in-depth analysis of the ones that starting 
recruitment at birth or shortly after birth.  
With this review, we aim to understand the European birth cohort’s panorama, their 
aims and general structure and also the methodology used. All the information 
gathered from this observation have been essential to define and launch NASCITA  
(NAscere e CREscere in ITAlia) a national birth cohort officially started on the 1st of 
April 2019. In this thesis, I will present the protocol, management and organization 
of these birth cohorts and some preliminary results.  
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 II.  AIMS  
I. To identify all the European Birth Cohort and to perform an in-depth analysis of 
the ones that starting recruitment at birth or shortly after birth. To understand 
the European birth cohort’s panorama, their aims and general structure and also 
the methodology used.  
II. To provide input for those creating collaborations and laying out guidelines 
aimed at unifying cohort methodologies to enable merging of data and 
maximise knowledge acquisition.  
III. All the information gathered from this observation has been essential to define 
and launch NASCITA (NAscere e CREscere in ITAlia) a national birth cohort 
officially started on the 1st of April 2019.  
IV. The main aim of the NASCITA cohort is to evaluate physical, cognitive, and 
psychological development, and health status, and health resource use during 
the first six years of life in a group of newborns, and to evaluate potential 
associated factors.  
V. To evaluate differences between geographical settings in educational and 
socialization opportunities available for young children and in the care provided 
by the family pediatricians and by the National Health Service for the same 
needs.  
VI. To evaluate the association between the well-being of children and parental 
adherence to the recommendations for better childcare and development.   
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VII. To understand how the influences of environmental factors and nurture, which 
also include the social context, can affect the process of child development and 
health, and its changes across time.  
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III.  STEPS (Methods)  
 A.  Step 1: An inventory of the existing European Birth Cohorts  
 A.1  Background  
Cohort studies collect data on a group of people in order to identify and quantify the relationship 
between exposure and outcome. They can be prospective or retrospective. 
In prospective cohort studies, the population is recruited regardless of exposure or 
outcome status and is followed for a set period until the disease or outcomes of 
interest occur [De Groot et al. 2017; Klebanoff et al. 2018]. In retrospective cohort 
studies the population and its medical events or outcomes are examined by looking 
at the past. The limitations of this kind of study are linked to the limited control that 
the investigator has over data collection, increasing the risk of incomplete, 
inaccurate or inconsistent data [Song et al., 2010]. 
 The increasing use of electronic health records has facilitated the development of a 
number of registries within large health plans.   Registries can also be used to collect 
data prospectively and continuously, as in the collection of medical record data, 
reflecting clinical practice. [Sessler et al. 2015] Both cohorts and registries can be 
started at different times, based on their aims, can be used for different scopes, and 
can collect data at different time points. There are different types of registries, from 
patient registries based on a disease or exposure, which collect data on patients 
with that characteristic, to those simply listing patients with specific diseases, e.g., 
rare diseases, but are not used for evaluating outcomes [Gliklich et al. 2014]. A 
cohort is more malleable and can be designed to identify causality between risk or 
exposure factors in early life and health in later life. Birth cohorts, which start from 
pregnancy or birth and follow newborns for a period of time, often into adolescence 
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or adulthood, are carried out especially with this aim, for example, to assess the 
impact of environmental exposure during development and its effects on adult 
health. Substantial evidence about this link has been found in recent years [Balbus 
et al. 2013], and increased attention is being placed on the prospective, longitudinal 
collection of data from participants throughout. Longitudinal cohorts permit the 
repeated collection of data and the study of various factors contemporaneously. 
These diverse factors range from those involved in nurturing care [Britto et al. 2017; 
Maggi et al. 2010], i.e., family structure, social and physical environment, schooling, 
and health and nutritional behavior, to exposure to environmental toxins such as air 
pollution, allergens, metals, pesticides, and smoking [Gehring et al. 2013]. All these 
factors have increasingly been acknowledged as having a significant impact on adult 
health [Lawlor et al. 2009] and birth cohorts are fundamental in understanding the 
extent of their effects. Scientific evidence has shown how simple actions involving 
the reduction of exposure to risk factors or the promotion of protective factors in 
the first few years of life can prevent significant health problems in children and 
adults.[Balbus et al. 2013; Barker 1998; Barouki et al. 2012; World Health 
Organization Regional Office for Europe 2013] 
Many birth cohorts have been carried out around the world and many are currently 
ongoing [Batty et al. 2007; Vrijheid et al. 2012; Larsen et al. 2013]. Europe, especially 
Northern Europe, has been particularly active. In this context, we reviewed 
European birth cohorts to analyze where they are based, the current enrolment 
status, their objectives, areas addressed, and age periods covered, with a focus on 
cohorts that started enrolment at birth and not in pregnancy. We aimed to generate 
a panorama of the current birth cohorts’ research topics and design and to provide 
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input for those creating collaborations and laying out guidelines aimed at unifying 
cohort methodologies emerging of data and maximize knowledge acquisition. We 
also aimed to understand how many birth cohorts address the impact of the family 
context (nurturing care) and the impact of the pediatricians’ care on child health and 
growth, to provide input for future cohort studies.  
  
 A2.  Materials and Methods   
Between January and July 2019, we performed a narrative review of the European birth 
cohorts taking into consideration multiple sources.  
  
A.2.1 Search strategy  
The search strategy is described in detail in Annex A. Inclusion criteria were: Birth 
cohorts that were based in a European country and collected longitudinal and 
prospective data on the babies. In order not to exclude pertinent publications, 
however, we chose search strategies with high specificity and low sensitivity and 
had to limit results via individual ascertainment. We searched PubMed and Embase 
with the last update on 1 July 2019, limiting the results to the 20th of May 2019, 
with no restriction on past publication years. We excluded randomized controlled 
trials and articles focusing on vaccines or genes or gene expression. Data were 
reported using the flow diagram proposed by the PRISMA statement for reporting 
Systematic Review and Meta-Analysis [Liberati et al. 2009].  
Records found were downloaded in the Reference Manager 12 software (Thomson  
Research Soft, Carlsbad, CA, USA).  






A.2.2 Data extraction  
The records were reviewed and, for each one, the name of the cohort it involved 
was noted. When this information was not available in the records’ abstracts, the 
articles were retrieved when possible. We also searched online birth cohort 
inventories to see if any additional cohorts could be found. In particular, we 
consulted the web-based database (http://www.birthcohorts.net), created as part 
of the Children Geno Network (a European FP5 Research Program) in 2005, and 
improved and redesigned within the European FP7 Program CHICOS project 
(http://www.chicosproject.eu). We also searched the cohorts listed by two EU-
funded research projects: The ENRIECO project [Chase et al. 1998] and the 
EUCCONET Network [Piler et al. 2017]. Exclusion criteria were: Vaccine studies, case-
control studies designed within existing cohorts, studies that applied gene analysis 
or other criteria in sample selection, or cohort studies focusing only on the parents 
or on pregnancy outcomes, that were exclusively retrospective, that collected data 
from registries, or that did not involve a follow-up. The European definition used 
was the UN definition [Doyle & Golding, 2009].  
We performed more detailed analyses on the subgroup of cohorts that began 
recruitment at birth and not during pregnancy. Cohorts that began collecting data 
after a few months of birth, even though patients were enrolled at birth, were 
included. For the more detailed analyses it was often necessary to search for 
additional scientific publications resulting from the single cohorts, in addition to the 
cohorts’ websites, to limit the amount of missing data. Two authors (Claudia 
Pansieri and Chiara Pandolfini) worked on different parts of the data extraction 
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process as well as on certain overlapping parts, and all cases of uncertainty, 
discrepancy, or missing data were resolved through discussion, searches for 
additional data sources, and consensus.   
The type of funding received by the cohorts was classified into four types: Public  
(ministries of health, hospitals, including university hospitals, etc.), Foundation,  
University, and Industry.  
  
 A.3  Results  
A.3.1 Identification of the Cohorts  
A total of 8572 articles were found through the internet-based bibliographic 
literature databases consulted, after the exclusion of duplicates as illustrated in the 
PRISMA flow diagram (Figure 4). Of these, 5444 articles referred to 111 birth 
cohorts, while 3128 articles were not pertinent mostly because they referred to 























 Figure 5.  Selection of articles and number of related cohort  
   
    
The large proportion of non-pertinent articles, since no specific indexed term exists 
in Medline or Embase for birth cohorts, led to the need for individual assessment of 
a large portion of abstracts or full-texts. Other cohorts, such as NCCGP North 
Cumbria Community Project [Pearson 2015], were also excluded because of a lack of 
basic information such as the enrolment period and the number of patients included 
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or expected and the consequent lack of any useful information. When the online 
birth cohort databases were searched for additional European cohorts, none were 
found. A total of 111 European birth cohorts were identified. Of these, 66 began 
enrolment in pregnancy (2 of which in pre-pregnancy) and 45 at birth or shortly 
afterward. References of articles referring to the 45 cohorts found are listed in  























A.3.2 The European Panorama   
The 111 European cohorts represented 27 different countries, including three countries 
represented only in the four multinational cohorts (Austria, Iceland, and Slovenia). The 
countries most commonly involved, in 16 cohort searches, were Germany and the UK, 
followed by the Netherlands (15). The number of children recruited in the different 
cohorts ranged from 107 to 10.8500 (median 1924). The starting year of enrolment in 
the different cohorts ranged from 1921 to 2016 (median 2002) and the duration of 
enrolment, excluding 10 with currently ongoing enrolment, and one with missing data, 
ranged from 1 to 23 years (median 2) (rounded to whole years). Concerning the follow-
ups, 62 have ongoing follow-ups, of which 22 are lifelong and the rest of which have a 
duration of 1 to 31 years. The median could not be calculated because of the general 
nature of the description of follow-up duration for several cohorts (e.g., young 
adulthood).  
  
A.3.3 The 45 Cohorts Starting Recruitment at Birth  
When only the subset of cohorts that began recruitment at birth was selected, 45 
cohorts were present (Table 2), representing 19 European countries, 7 (37%) of which 
are located in Northern Europe, and 11 (58%) in Northern or Western Europe (Figure 6). 




Table 2. The 45 European birth cohorts analysed  









Data origin2  
Genetic 
analysis  
Biological samples (if taken)  
Belgium   ENVIRONAGE  1080  2010  Ongoing  Q, PV  SR  Yes  Cord blood   
Belgium  FLEHS-I  1196  2002  Closed  Q, PV  SR  Yes  
Blood, Cord blood, Exhaled breath 
condensate, Meconium, Saliva  
Czech  
Republic  
CzECH  7577  1994  Closed  Q, PV  SR/PED  Yes  Cord blood, Urine  
Denmark  CCC2000  6090  2000  Closed  PV  PED  No    
Denmark  DARC  562  1998  Closed  Q, PV  
SR/GYN- 
HCP/PED  
No  Blood  
Finland   NFB C8586  9479  1985  Closed  Q  SR  No  Info missing  
Finland  TURKU  5356  1981  Closed  PV  GYN-HCP/PED  No    
France   AuBE  302  2009  Closed  Q  SR  No  Colostrum   
France  ELFE  18326  2011  Ongoing  Q  SR  No  Cord blood, Hair, Urine  
France   Epifane  3368  2012  Closed  Q  SR  No    
France   EPIPAGE 2  5567  2011  Ongoing  Q, PV  SR/GYN-HCP  No    
France   PARIS  3840  2003  Ongoing  Q, PV  SR/PED  No  Serum  
Germany  DONALD  1300  1985  Ongoing  Q, PV  PED  No  Urine  
Germany  GINIplus  5991  1995  Ongoing  Q, PV  PED  Yes  Cord blood, Serum  
Germany  KUNO  2515+  2015  Ongoing  Q, PV  SR/PED  Yes  
Buccal swab, Cord blood, Gingival smears, 
Hair, Skin swab, Stool, Urine  
Germany  LISA PLUS  3097  1997  Closed  Q  -  Yes  Serum  
Germany  MAS-90  1314  1990  Closed  Q, PV  GYN-HCP/PED  Yes  Blood, Cord blood, Urine   
Germany  SPATZ  1006  2012  Ongoing  Q  SR  No  Blood, Breast milk, Hair, Urine  
Germany   UBCS  1022  2000  Closed  Q  SR  Yes  Breath test, Serum  
Italy   ITAL NEONAT  697  2009  Closed  Q, PV  PED  No  Info missing  
Italy  GASPII  708  2003  Ongoing  Q, PV  PED  Yes  Blood, Cord blood, Serum  




N.  Enrolment  Follow up  Data  2  Genetic  Biological samples (if taken) Nation 
 Acronym  children  start  status  collection1  Data origin analysis  
Italy  Piccolipiù  3328  2011  Ongoing  Q, PV  SR/PED  Yes  Blood, Cord blood, Urine   
Multicenter   Europrevall  12049  2005  Ongoing  Q  SR  Yes  Blood, Cord blood,  
Norway   ECA  3754  1992  Closed  Q, PV  SR/PED  Yes  Cord blood   
Norway  HUMIS  2000  2003  Ongoing  Q  SR  No  Breast milk, Cord blood  
Portugal   G21  8647  2005  Ongoing  Q  -  No  Cord blood, Serum  
Slovakia  PCB  1134  2002  Closed  Q, PV  SR/GYN-HCP/PED  No  Cord blood  
Slovakia  PRENATAL  1990  1997  Closed  Q, PV  GYN-HCP  Yes    
Sweden   ABIS  16058  1997  Closed  Q, PV  PED  Yes  Blood, Breast milk, Serum  
Sweden   BAMSE  4089  1994  Ongoing  Q  SR  Yes  Blood, Plasma, Urine  
Sweden   H2GS  2026  2007  Closed  Q, PV  SR/PED  No    
The Netherlands   Dutch  236  1990  Closed  Q, PV  SR/GYN-HCP/PED  No    
The Netherlands   LucKi  5000  2006  Ongoing  Q, PV  SR/GYN-HCP  No  Meconium  
The Netherlands  TERNEUZEN  2604  1977  Closed  Q, PV  -  No    
The Netherlands  WHISTLER  2923  2003  Ongoing  Q  -  No    
Turkey   ADAPAR  1377  2010  Closed  Q, PV  SR/PED  No  Cord blood, Serum  
UK  ABERDEEN  668  1921  Closed  Q, PV  GYN-HCP  No    
UK   EPICure  308  1995  Ongoing  Q  -  No    
UK   FAIR  969  2001  Closed  Q  SR  No    
UK   GEMINI  2402  2007  Closed  Q  SR  No    
UK   GMS  1029  1999  Ongoing  Q, PV  SR  Yes  Blood, Saliva  
UK   GUS  5217  2004  Ongoing  Q  SR  No    
UK   LRC  10350  1985  Ongoing  Q  SR  No  Saliva   
UK   TEDS  21000  1994  Ongoing  Q  SR  Yes  Info missing  
1. Q: questionnaire, PV: Patient visit.  
2. SR: Self-reported questionnaire by parent; GYN-HCP: Medical information directly from gynaecologists or other health care 









The starting years of these cohorts ranged from 1921 to 2015 (median 2002). More 
than half of the cohorts began in 2000 or later and 8 after 2010. The sample size of 
each cohort varied considerably, from 236 of the 1990 Dutch cohort to more than  
21000 children of the TEDS-Twins early development study, with a mean of 4230 
(median 2515). The two largest birth cohorts are located in the UK (TEDS-Twins 
early development study, with 21000 children enrolled) and in FRANCE (ELFE- Etude 
Longitudinale Francaise depuis l’Enfance, with 18326 children enrolled).  
The oldest of the 45 cohorts enrolled participants in 1921 (the 1921 Aberdeen Birth 
Cohort) and the youngest began enrolment in 2015 (the German KUNO-Kids birth 
cohort) (Figure 7). As of January 2020, the majority of cohorts were closed to 
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recruitment since they completed the enrolment of child participants. Five cohorts 
are currently still recruiting: DONALD (begun in 1985), GUS -Growing Up in Scotland  
(2004), KUNO-Kids (2015), the LucKi birth cohort (2006), and MUBICOS (2009). 
Concerning the follow-up, 49% (22/45) of the cohorts are still undergoing follow-up, 
while the rest are definitively closed. Concerning the more recent cohorts, fifteen of 
the 26 (58%) cohorts set up from 2000 on, and 6 of the 8 (75%) from 2010 on, are 
currently ongoing.  The duration of the follow-ups ranged from 1 year to life-long 
(Figure 7).  
  
Figure 7. Cohorts’ enrolment period, follow-up status (Ongoing/Closed), and 






The aims behind the creation of the cohorts are various and cover a broad range of 
aspects of child health. The most frequently studied individual topics included: 
allergic diseases (14 cohorts), environmental exposure (12), and growth (intended 
as physical growth, 10), although several cohorts (28) addressed multiple areas and 
were designed to test a wide range of hypotheses (Figure 8). Allergic diseases were 
most often studied in terms of their association with environmental exposures and 
asthma, but also with autoimmune diseases, lifestyle exposure, nutrition, and 
obesity. The environmental exposure was also studied together with genes, lifestyle 
exposure, neurocognitive development, and twin development, but also with 
asthma, autoimmune disease, growth, and nutrition. Growth was also studied 





















When divided into three groups based on the age of the cohorts to see if, over time, 
the priorities studied changed, allergic diseases and environmental exposure were 
more recent priorities. Both were initially studied to a limited extent. Allergic 
diseases resulted as a priority area among the cohorts for the first time in 1990 and 
environmental exposure in 1992. More specifically, in the 1921-1995 period, growth 
(5 cohorts) and allergic diseases, environmental exposure, and nutrition (3 each) 
were the most commonly addressed areas, between 1997-2004, they were, allergic 
diseases and environmental exposure (7 cohorts each), and in 2005-2015 they were 
allergic diseases (4), and growth and general areas with multiple aims (3 each).  Only 
three cohorts addressed the impact of the family context (nurturing care) to a 
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certain extent among their goals, the ELFE, Epifane, and GUS cohorts. All three of 
these cohorts were relatively recent (2011, 2012, and 2004, respectively).  
  
 A.4  Discussion  
In this review, we provide up to date information on birth cohorts in Europe with a 
focus on those that began data collection at birth.  
The fact that more than half of the cohorts began in 2000 or later and that many are 
still ongoing in terms of follow-up of participants suggests that there is a current, 
active interest in newborns, although with the involvement of only 9 countries, and 
with different aims.   
The number of participants included varied largely, although the average was only 
just over 4000. With larger sample sizes, aided by the use of standard measures in 
the pooling of cohorts, and the joining of data from large epidemiological studies 
from other countries, it is possible to understand the epidemiology of diseases [Piler 
et al. 2017]. A long follow-up period is fundamental to assess the impact of different 
factors on adult health and to be able to identify possible corrective interventions. A 
powerful limiting factor in setting up, and running, large cohorts over large periods 
is the cost [Doyle & Golding 2009]. Two very large studies in the UK and US have, in 
fact, recently been cancelled also due to budgetary issues. [Pearson 2015;  
Cernansky 2017]  
More than a third of the European cohorts were established in northern Europe, 
where this kind of study has a long-lasting tradition. Health surveillance (perinatal 
and not) in this area of the world is often of high quality also because of the use of 
record linkage between health, civil and administrative data [Furu et al. 2010]. Two-
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thirds of the cohorts were established in Northern or Western Europe, and high-
income countries in all except one case. These data are similar to those of Larsen et 
al, which included pregnancy cohorts as well, and whose cohorts were limited to 
those of greater entity and limited to 2013 [Larsen et al. 2013].  
Unlike the work carried out by Larsen and colleagues [Larsen et al. 2013], we limited 
the analysis to European cohorts starting enrolment of the babies after birth. This 
was done because we wished to focus our study on child development in general 
and on the impact of nurturing care. We, however, reported in the data the cases in 
which the cohorts included retrospective pregnancy data.  
The main areas addressed by the cohorts were allergic diseases and environmental 
exposure, both of which have become priority study areas more recently. The 
numerous cohorts addressing environmental exposure reflect increasing attention 
to the negative effects of pollution on health. Growth was studied more by the 
older cohorts, while obesity is a new research area, although all of the areas 
currently remain topics of interest for research, expansion of knowledge, and 
appropriateness of interventions. Many cohorts were designed to test a wide range 
of hypotheses, such as the Spatz cohort [Braig et al. 2017]. This approach addresses 
the identification of many risk factors for disorders thought to have a 
perinatal/early life aetiology such as birth defects, respiratory conditions, and 
childhood cancer [Golding et al. 2017;  
Guyatt et al. 2015]. Other cohorts were more focused on specific topics, such as 
respiratory diseases (e.g. the LRC cohort) [Kuehni et al. 2007]. Exposure to a pattern 
of adverse early-life stressors, in specific age windows, influence health throughout 
the life cycle. The scientific evidence currently available shows how even events 
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occurring shortly after conception and up until the time a baby is delivered may lead 
to diseases and morbid events. These may be either present at birth or may 
manifest themselves later in life, in early childhood and or in adult age [Barker 1998; 
Barouki et al. 2012; Barker 2004; Latzin et al. 2009]. Several stressors have already 
been identified through the exploration of data from historical birth cohorts [Power 
& Elliott 2006]. The early-life stressors that recently reached scientific attention are 
socioeconomic circumstances, migration, urban environment as well as lifestyle-
related determinants [Lynch & Smith 2005].  
The research results show that few cohorts have followed in detail child 
development as well as neurodevelopment. In general, child health is a product of 
biological factors and diverse sets of environmental influences, including 
intrauterine and social ones  
[Lawlor et al. 2009; Barker 1998; Barouki et al. 2012; World Health Organization 
Regional Office for Europe, 2013; Batty et al. 2007; Vrijheid et al. 2012; Prado et al. 
2019]. This implies that high-quality measures of multiple dimensions of both sets of 
influences need to be taken during appropriate developmental periods. Epigenetic 
and phenotypic measures and their associations with health outcomes since 
conception and/or birth are increasing aims of prospective cohort studies [Corley et 
al. 2019]. The collection of biological samples, conducted by the majority of the 
ongoing cohorts, has increasingly become part of routine data collection [Bailey et 
al. 2017] given its importance in studying the biological mechanisms of disease, and 
also permitting the measuring of biomarkers of environmental exposures. Biological 
samples, in fact, allow researchers to study how social and environmental factors 
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leave biological imprints, independent of, or in combination with, genetic 
background [Richmond et al. 2014].  
The cohorts were supported mostly by public funds. Setting up and running cohorts, 
especially over long periods of time, is very important but is also extremely costly. 
More economic support would be useful for setting up cohorts in all countries, and 
for making it possible to collect enough information, and in a suitable format, to 
make the cohorts comparable enough to merge their data with that of other 
cohorts. The industry had a limited presence in the cohorts described in this review.  
The limited funds available for running cohorts inevitably influence the type of data 
collection employed. While most of the cohorts collected data via predefined 
questionnaires and face-to-face interviews, which are less costly, patient visits 
involving clinical assessment were carried out in just over half the cohorts. The 
Nordic countries often draw patient data from different inter-related registries, 
facilitating the collection of also clinical data, and reducing costs [Cernansky 2017; 
Sørensen 1997]. The cohorts also used hospital records to obtain data on the 
mothers, the pregnancies, and the births, facilitating the collection of sufficient data 
from which to calculate correlations with subsequent events. The use of web-based 
questionnaires in assessing perinatal outcomes has also been found to be a valid 
way to collect data while limiting costs [van Gelder et al. 2017].  
The lack of commonly acknowledged guidelines on the use of common measures for 
data collection, along with the various data sources used by cohorts, leads to the 
extreme difficulty in merging or comparing data from different cohorts, a process 
that would permit more far-reaching, significant conclusions from the research. This 
is a well-recognized issue and different groups are working to address it.  
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Few cohorts also focused on family context (nurturing care) and its impact among 
their research areas. Family context is a fundamental issue [Britto et al. 2017] and 
should be a priority study area.The cohorts that at least partly investigated the 
family context was relatively recent and were set up around the years when the 
Lancet series addressing the evidence linking early childhood development with 
adult health and wellbeing began [Jones 2018].  
Few cohorts involved the general pediatrician (or the general practitioner) as the 
person delegated to collect data, highlighting the fact that primary care is a 
neglected resource for research [Bhutta et al. 2008]. With their clinical practice, 
pediatricians are most in contact with patients and can promote study and action. 
Pediatricians can play a role both in the education of parents and other caregivers, 
and in the implementation of curative, preventive, and health-promoting 
interventions through their professional practice. They can work together with 
other professionals in the development and execution of research with special 
attention to child growth and development, child mental health, and, in general, to 
the well-being of future generations.  
Our aim was to describe the birth cohorts’ research topics and design, to 
understand their interest in the impact of the family context (nurturing care) and 
the general pediatricians’ role in child care and data acquisition, and to provide 
input for future cohort studies and for those working towards universally 
acknowledged guidelines for unifying cohort methodologies to enable data merging 
and the consequent maximum acquisition of knowledge. The results of this study 
show that a limited number of countries participates in multinational birth cohort 
studies and that adequate, universally recognized methodological aspects (e.g., 
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sample size, data collection, and follow-up duration), and common health priorities, 
are needed to permit the comparison and merging of cohort data. Such an 
expanded amount of comparable data would permit researchers to draw more solid 
conclusions and stakeholders to implement the knowledge in initiatives aimed at 
improving people’s health.  
To our knowledge, this is the first inventory of birth cohorts, both at the European 
and worldwide level, starting recruitment after birth. Considering pregnancy and 
birth cohorts together, inventories have been produced in Canada [Joly et al 2012] 
and Asia [Kishi et al. 2017]. Several collaborations addressing specific research 
questions including several worldwide birth cohorts, however, were set up in the 
last few years, such as the Environment and Child Health International Birth Cohort 
Group  
(ECHIBCG) [Nakayama et al. 2019] and the CODATwins Project [Silventoinen et al. 
2019]. The only indispensable tool that can easily be searched and that accepts 
registration from pregnancy and birth cohorts established all over the world is 
www.birthcohorts.net. Potential limits of this study exist. It is possible that we did 
not identify all the European birth cohorts, but we attempted to use the most 
rigorous and extensive search strategy for identifying the cohorts, so we expect that 
a potential percentage gap would be small. This review is descriptive; we did not 
contact the principal investigators of the cohorts but searched for information only 
via web, and this may have limited the completeness of data or led to partial data, 
since data found in one publication may be different from those in other 
publications referring to the same cohort. Furthermore, classifying the cohorts’ aims 
into individual scientific areas was difficult given the overlap between areas (e.g. 
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lifestyle and environmental exposures), but the distinction was useful to provide a 
general description of the cohorts and to show their differences. For example, the 
four remaining cohorts labelled as addressing general areas with multiple aims were 
not classifiable because their aims were so widespread. The strengths of this study 
are that it reports on a large number of active initiatives whose role is to look 
ahead, starting from birth, to monitor the development of European newborns. The 
findings of these cohort studies can be useful for stakeholders in allocating 
resources towards appropriate endeavours in order to work towards improving the 
health of citizens from birth.  
  
  
A.5. Conclusions  
The continuing follow-up of existing cohorts is the most efficient way to detect 
areas of improvement and windows of collaboration. Longitudinal data investments 
need to be directed at capturing the circumstances of tomorrow’s children and 
adults, i.e. current cohorts must be able to answer upcoming research questions 
considering several aspects: genetic and biological, psychological/social 
environments, medical care and medications, and lifestyle and environmental 
parameters. In this regard, new cohorts are periodically being set up to address the 
more pressing issues, such as child health and pollution.   
We also believe that primary care should be supported, exploited and valued in 
public health research. Future studies should involve close collaboration with family 
pediatricians, or physicians caring for children, since in this new vision their role will 
no longer be limited to the treatment of diseases, but will involve the global 
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assistance of the child and family. The present study reveals the involvement of only 
a few countries. Shortly, more countries should be involved in multinational birth 
cohort studies, with adequate, universally recognized methodological aspects (e.g., 
sample size, data collection, and follow-up duration), with common health 
priorities. The role of the European Commission, in addition to supporting the setup 
of such multinational cohorts, is to promote, and eventually require, the 
implementation of commonly acknowledged parameters to allow for comparison of 
cohorts and data merging to maximise the acquisition of knowledge from such 
studies.  
  
    
 A.6  A view on major extra Europe longitudinal studies and initiatives  
In a recent review, Waleska and colleagues [Waleska et al. 2018] identified around 
84 cohorts all around the world.  
Of the 84 cohorts identified, 41 were birth cohorts, 41 were prenatal cohorts, and 2 
were preconception cohorts. Of this 64 have a prospective design with longitudinal 
data collection.   
Of the 84 cohorts identified, 40 were in Europe, 4 in Africa, 13 in the Americas, 15 in 
Asia, and 12 in Oceania. See Figure 9.  
The size of each marker is proportional to the initial membership of each cohort, 
and the colours of the markers indicate whether the study involved a 






Figure 9. Map of the world showing the location of the preconception, prenatal, and 





The most complete overview of the birth cohort studies conducted in Africa (Figure 
1) was reported by Campbell and Rudan around 10 years ago [Campbell et al. 2011].  





UNITED STATES  
No systematic review on birth cohorts established in the United States were found. 
The biggest birth cohort in the United States is the National Children’s Study (NCS or 
Study) This study aimed to recruit a nationally representative longitudinal cohort 
study of 100,000 children from before birth through age 21 to examine the effects 
of a broad range of environmental and biological factors on children’s health and 
development. It was closed in December 2014.  
CANADA  
An inventory of Pregnancy and Birth Cohort Studies in Canada was performed in 
2009 by Joly and colleagues [Joly et al. 2012].  
They identified 46 birth cohort studies. (Figure 11) The details of data collected have 
been uploaded on the website of IHDCYH: hiip://www.cihr -irsc.gc.ca/e/40753.html.  
  





AUSTRALIA AND NEW ZEALAND  
Townsend and colleagues in 2016 performed a systematic review collecting birth 
cohorts from Australia and New Zealand.  The studies undertaken in these 
developed regions are characterised by particular social ecologies and policy 
environments that differ from other countries, with the populations eligible for 
universal and quality health care and education, living in clean environments with 
less defined class based society and diverse cultural backgrounds. 
They identified 23 studies, he 83% of studies identified are of prospective 
longitudinal birth cohort design. Authors reported an increasing interest and 
acknowledgment of the value in collecting detailed data on parents and 
grandparents, not just the index child [Townsend et al. 2016].  
  
ASIA  
The Birth Cohort Consortium of Asia (BICCA)  
BICCA includes 27 birth cohorts with approximately 80,000 study subjects that were 
conducted in 13 Asian countries and provides an information exchange platform for 
birth cohort in Asian countries [Kishi et al. 2017].  
  
SOUTHEAST ASIA AND EASTERN MEDITERRANEAN  
McKinnon and colleagues performed a Systematic Review of birth cohort studies in 
South East Asia and Eastern Mediterranean Regions in 2011 (Figure 12). They 
detected 120 studies in total located mainly in the SEA region (n = 83) compared to 
the EM region (n = 37). An overview of studies revealed large diversity in their 
methodologies, most of the studies that declare collection on biologic samples are 




   Figure 12. Location of the asian birth cohorts  
  
  
MIDDLE EAST  
No systematic review on birth cohorts established in the Middle East has been 
detected. One of the principal birth cohorts is The Mother-Infant Study Cohort 
(MISC) that is an ongoing two-year prospective cohort study which recruited Arab 
pregnant women in their third trimester from prenatal clinics in Dubai, Sharjah and 
Ajman [Radwan et al.  
2018].  
  
INTERNATIONAL INITIATIVES  
The Global Longitudinal Research Initiative (GLORI 2.0)  
The Global Longitudinal Research Initiative (GLORI 2.0) is a research network of 
longitudinal researchers working on topics relevant for children, an initiative 
promoted by the UNICEF aiming to tracks longitudinal research projects looking at 
child development trends and trajectories around the world. Set up in 2014, the 
network has members working in over 30 countries. (Figure 13) This is a developing 
community of practice seeking to: Add to the evidence base through a coordinated 
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approach; Create an inventory of resources and harmonise tools in some areas; 
Document and share best practice; Develop mechanisms to strengthen institutional 
capacity and local ownership; [UNICEF, 2013].  
  
Figure 13. GLORI 2.0 - Currently Studies country  
  
  
ReACH  -  The  Research  Advancement  through  Cohort 
 Cataloguing  and Harmonization  
The Research Advancement through Cohort Cataloguing and Harmonization 
(ReACH) initiative was formally established in 2016. ReACH initiative is funded 
through a CIHR Operating Grant for the Canadian DoHaD Cohort Registry (2016-
2021).  
ReACH initiative will provide resources in the form of a comprehensive web-based 
catalogue and a harmonization platform to optimize and expand the use of  
Canadian pregnancy and birth cohorts data and biological samples.  
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The Consortium of Health-Oriented Research in Transitioning Societies  
The  Consortium  of  Health-Oriented  Research  in  Transitioning 
 Societies, encompassing 5 of the largest birth cohorts located in low- and middle-
income countries (Brazil, Guatemala, India, the Philippines, and South Africa), with the 
fundamental objective of providing high-quality scientific data on the early origins of 
chronic diseases and human capital, has evaluated data related to approximately  
22,840 children [Richter et al. 2012].  




B. Step 2: NASCITA (NAscere e creSCere in ITAlia) a new birth cohort  
B.1. The protocol  
B.1.1 Background: Nurturing care  
Childhood development is a maturational process resulting in an ordered 
progression of perceptual, motor, cognitive, language, socio-emotional, and self-
regulation skills. The acquisition of skills throughout the life-cycle, therefore, builds 
on the foundational capacities established in early childhood. [Black et al. 2017]. 
Multiple factors influence the acquisition of competencies and skills, including 
health, nutrition, security and safety, responsive caregiving, and early learning. All 
are necessary for nurturing care [Black et al. 2017; Lancet’s Series 2016]. Nurturing 
care reduces the detrimental effects of disadvantage on brain structure and 
function which, in turn, improves children’s health, growth, and development [Black 
et al. 2017; Meuter et al. 2015]. Nurturing care is characterized by a home 
environment that is sensitive to children’s health and nutritional needs, responsive, 
emotionally supportive, and developmentally stimulating and appropriate, with 
opportunities for play and exploration and protection from adversities [Black et al. 
2017; Singla et al. 2015]. Nurturing care extends beyond families to include 
community caregivers for families [Black et al. 2017; Lancet’s Series 2016; Meuter et 
al. 2015; Singla et al. 2015; Bellman & Vijeratnam 2012]. The environmental, social, 
economic, political, climatic, and cultural contexts can therefore affect nurturing 
care and early childhood development. Infancy and childhood are characterized by 
rapid growth and development, and are considered critical periods of development 
in life that strongly contribute to health status, well-being, and behaviour across the 
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lifespan [Lancet’s Series, 2016]. Many common diseases and challenges in adult life 
can be traced back to early childhood [Black et al. 2017; Barouki et al. 2012].  
  
B.1.2 The Italian context  
The heterogeneity of the population in Italy is increasing, and sociodemographic 
and factors (e.g., in education and migrant status) associated with health disparities 
have been increased [Bonati et al. 2005; Landi et al. 2018]. In this context to 
adequately describe public health in Italy, epidemiological studies enrolling 
participants from all population groups and settings are therefore needed. Although 
Italy has a public, universal healthcare system that should pose no legal or financial 
barriers to subgroups of the population, considerable health inequalities exist 
[Corsello et al. 2016]. Differences arise from differences in factors such as health 
behaviour, exposure, environment, genes, etc. Life-course approaches show that a 
considerable part of these inequalities is determined by exposure, health status, 
and development in utero and early childhood [Black et al. 2017; Barouki et al. 
2012]. Moreover, in early childhood, children are particularly vulnerable to the 
influence of different factors and their interactions. While this fact is well 
documented, underlying mechanisms remain unclear. It is still poorly understood 
how specific social factors, socioeconomic status, living conditions, parental and 
stakeholder care, and attitudes act on the well-being of children or in creating 
health inequalities among children. Moreover, interactions between these factors 
need to be investigated [Pillas et al. 2014; Andrea et al. 2017; Christian et al. 2015].  
As well described in the introduction, birth cohort studies are a powerful study 
design for medical and social research because they are designed to observe the 
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impact of early exposures prospectively and at multiple time points during child 
development [Lawlor et al. 2009]. Several birth cohort studies have been carried out 
[Larsen et al. 2013], also in Italy [Richiardi et al. 2018; Farchi et al. 2014], with 
different aims and sizes.  
The overall aim of the NASCITA study (NAscere e creSCere in ITAlia) is to improve 
the understanding of the health status of Italian children early on and how it is 
affected by social and health determinants. Like many other cohorts, it will address 
multiple research questions [Richiardi et al. 2018; Farchi et al. 2014]. The findings 
will add important evidence, in terms of epidemiological data, for the development 
of specific prevention measures and interventions to improve the health status of 
children, in particular more vulnerable ones.  
  
B.1.3 Hypothesis and significance  
We hypothesize that:  
• differences due to environmental, sociodemographic, and parental determinants, 
as well as to child characteristics and physician attitudes, exist between 
geographic areas in a population’s health and the use of health resources in the 
first few years of life;   
• differences exist in the appropriateness of care provided by the National Health 
Service at different levels (regional, local, family pediatrician);  
• differences exist in parental attitudes toward the recommendations concerning 
children’s health care and these differences may be a determinant of child 




• the existing differences between locations in the opportunities for children to 
access educational/ socialization experiences (e.g. day-care centers) may have an 
impact on development.  
  
B.1.4 Aims  
The main aim of the NASCITA cohort is to evaluate physical, cognitive, and 
psychological development, health status and health resource use during the first 
six years of life in a group of newborns, and to assess associations between factors. 
The specific research topics are:  
• the relationship between child development and the domains that affect 
nurturing care during the preschool period: health (disease prevention and 
treatment), nutrition (breastfeeding and dietary approach), safety and security 
(care and early intervention for vulnerable children), responsive caregiving 
(caregiving routine), and early learning (home opportunities to explore and 
learn);  
• the association between the well-being of children and parental adherence to 
the recommendations for better child care and development;   
• the potential factors influencing child well-being and growth and development, 
including the acquisition of competencies;  
• the differences between geographical settings in educational and socialization 
opportunities available for young children and in the care provided by the family 





    
B.2. Methods  
B.2.1 Study area and setting   
Italy is located in southern Europe and comprises the long, boot-shaped Italian 
peninsula, the southern side of the Alps, the large plain of the Po Valley and some 
islands including Sicily and Sardinia. Almost 40% of the Italian territory is 
mountainous, and there is a coastline of 7600 km on the Adriatic Sea, Ionian Sea, 
Tyrrhenian Sea, Ligurian Sea, Sea of Sardinia and Strait of Sicily. Italy is subdivided 
into 20 regions and is further divided into 14 metropolitan cities and 96 provinces, 
which in turn are subdivided into 7960 municipalities. A gaping North-South divide 
and can be noted by the huge difference in income between the northern and 
southern regions and municipalities [Eurostat 2017]. Twenty-two geographic 
clusters were identified as representative of the country based on locations and 
socio-economic characteristics and administrative divisions, using the National 
Statistics Institute definitions for each town/city [ISTAT 2020]. 
See Figure 15 for the geographical distribution of the NASCITA cohort. Pediatricians 
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Figure 15. Geographical distribution of NASCITA birth cohort  
  
  
Italian healthcare is provided free or at a nominal charge through a network of Local 
Health Units (LHU). Each LHU consists of a number of healthcare districts, which are 
population-based territorial entities that aggregate different municipalities. Every 
Italian resident is registered with a family (pediatric or general) practitioner. 
Children are assigned to a pediatrician until they are 6 years old; afterward, the 
parents can choose to register a child with a general practitioner. All adolescents 
 
77.  
>13 years old are assigned to a general practitioner. In Italy, there are about 7500 
family pediatricians, for an average of 450.000 births/year [Corsello et al. 2016]. 
About 60 newborns/year are therefore assigned to each pediatrician. All children 
are  
scheduled 7 well-child visits during their first 6 years of life (within 45 days of life 
and at 3, 6, 12, 24, 36, and 72 months of age). This list includes the recommended 
age for each well-child visit by the family pediatrician to ensure necessary 
preventive care, monitor a child’s growth and development, and establish a 
relationship between the child and his/her parents and the pediatrician.  
  
B.2.2 Study design  
NASCITA is an ongoing, dynamic, prospective, population-based birth cohort study. 
From the start of 1st April, 2019 newborns will be continuously included in the study 
for (at least) an entire one-year period chosen by each participating family 
pediatrician and will be followed prospectively until at least the age of 6years. Given 
the ongoing character of the study, no maximum number of inclusions has been set.  
  
B.2.3 Participants characteristics  
The study population of the NASCITA cohort study consists of all Italian children 
born during (at least) one year starting from the 1st April 2019, who will be followed 
by participating pediatricians until the age of 6 years and whose parents agree to 
participate. Data on all newborns, including those with special conditions or 
disabilities, e.g., congenital malformations, will be collected and reported. The 
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characteristics of the population with special condition will be evaluated separately 
in the analyses and a differential report will be produced.    
B.2.4 Inclusion and exclusion criteria  
The inclusion criteria for participating in NASCITA are:  
• To be born in Italy.  
• Date of birth > 1st April 2019 or during the period chosen by each pediatrician 
participating in the cohort study. That, in any case, could not be previous of this 
data.  
• Parents’ consent to participate signing the informed consent.  
Exclusion criteria:  
• Children born outside Italy  
• Children whose parents do not agree to participate, or decide to withdraw, will 
be excluded from the study.  
The recruitment embedded in Italian pediatric primary care practice. The 
coordination center has collaborated over the years with a network of hundreds of 
family pediatricians, as documented by numerous collaborative publications 
[Clavenna et al. 2014; Piovani et al. 2014; Cazzato et al. 2001; Nova et al. 2008], 
which represents the first interlocutor to whom we proposed participation in the 
study. The basis of this network is the national Pediatric Cultural Association (ACP), 
with around 2000 members consisting mainly of family pediatricians.  
To have as large a sample as possible we therefore used the already existing 
network to begin the first identification of the locally representative pediatricians, 
who were then asked to identify additional pediatricians, not necessarily belonging 
to the ACP, in their areas for participation. Other pediatric scientific societies and 
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associations have been contacted to expand collaboration and the number of 
participating pediatricians. In this regard, detailed information concerning the study 
will be disseminated through national pediatric journals and internet-based 
resources to increase recruitment. Recruitment was based on the voluntary 
participation of interested by pediatricians who, however, can guarantee seven 
years of professional activity so that they can follow the enrolled newborns for the 
whole study period. This approach to enrolling pediatricians can be defined as a 
mixed-method using also non-probability sampling techniques (convenience and 
purposive sampling) applied to choose a sample of subjects/units from a population 
[Palinkas et al. 2015].  
  
B.2.5 Pilot phase  
The already existing network of ACP members was contacted to begin the first 
identification of the locally representative pediatricians. Ideally one for each region. 
The project was firstly discussed with the president of the ACP. A group of family 
pediatrician participated in the pilot phase in which examples of case report forms 
were discussed and tested. In this phase was also tested the time needed to fill the 
forms. The time was recorded by each participant and difficulties or doubts were 
reported to the coordinating centre. The participants in the pilot phase assured the 
coordinating team that the data collection was feasible.  
  
B.2.6 Recruitment  
There were double steps of recruitment one dedicated to the family pediatrician 
and one to the newborns.  
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Pediatrician recruitment: Firstly, regional coordinators were identified, contacted 
and trained. Then they were asked to identify additional pediatricians, not 
necessarily belonging to the ACP, in their areas for participation. Other pediatric 
scientific societies and associations have been contacted to expand collaboration 
and the number of participating pediatricians. In this regard, detailed information 
concerning the study will be disseminated through national pediatric journals and 
internet-based resources to increase recruitment.  
Then we asked to start the recruitment of the newborns. Pediatricians could choose 
independently when to start the recruitment within a period comprised between 
the 1st April 2019 and the 30th September.  
Newborns recruitment: Recruitment of the newborns (and their parents) take place 
during the first routine well-child visit scheduled for all newborns within their first 
45 days of life at the office of the pediatrician assigned to them by the LHU to which 
they belong. Parents received oral and written information about the purpose and 
methods of the study and have been invited to participate. If they agree to 
participate, they have been asked to sign an informed consent. Recruitment of 
newborns will begin in April 2019.  
  
B.2.7 Study population size  
The NASCITA cohort is sized to have enough power to study relatively common child 
exposures and outcomes. Table 3 reports the national prevalence of certain health 
characteristics of Italian children and the expected number of cases for different 
enrolling scenarios to obtain a minimum number of participants that would permit 
all these characteristics to be sufficiently represented.  
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The aim is to recruit no less than 5000, and hopefully at least 10,000, newborns with 
complete information collected throughout the study. We hypothesize that, given 
the fact that the data collection is based on routine visits by the pediatrician, 
attrition in NASCITA will be irrelevant for at least the first two years. Considering the 
previous experience of other Italian cohorts, NINFEA [Richiardi et al. 2019] and 
PiccoliPiù [Farchi et al. 2014], we estimate a 20% loss to follow-up after the first two 
years. With an expected minimum of 5000 newborns, representing about 1% of the 
newborns in Italy, and with an estimated 20% loss to follow-up, the resulting sample 
size of 4000 children will still give NASCITA enough power to study common 
childhood exposures and outcomes [Farchi et al. 2014]. With the parents’ consent, 
data on children withdrawing after 12 months of age will be considered in the 
analysis for the relevant time period of participation (e.g. rate of exclusive 
breastfeeding, reading out loud, SIDS prevention, etc.). Data will be deleted upon 













 Table 3.  National prevalence of certain health characteristics of the Italian children  
and the expected cases for different enrolling scenarios in the NASCITA 





 B.3  Training and tutorial activities  
As described above, before the start of the study, family pediatricians have been 
involved in training activities. Local coordinators have been trained by the research 
team, and they have been responsible for the training of their peers at the local 
level. A case report form (CRF) was created in an online form with the contribution 
of local representatives of family pediatricians and scientific committee participants.  
During an initial phase (Pilot phase), a group of family pediatricians tested the 
electronic CRF (eCRF), leading to improvements and adding the necessary questions 
to achieve an eCRF that would allow a more complete and simple collection of data. 
The eCRF has been made available online before the start of the enrollment period 
to let participating family pediatricians familiarize themselves with the information 
that needs to be collected.  
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Central and local monitoring of the study have been scheduled with the aim to 
guarantee follow-up of the infants and the quality of data collected.  
  
 B.4  Data collection  
Data considered for the basic CRF are part of those routinely collected by the family 
pediatricians at the 7 standard well-child care visits scheduled for all children during 
their first 6 years of life, and data collected during each contact with the enrolled 
children.  
In the Italian setting small differences exist in numbers (from 5 to 9) of well-child 
care visits, to standardize the number of visits in NASCITA we fixed at 7 collections 
of data requested for all the Italian territory. See Figure 16 for the timeline of data 
collection, follow-up, and milestones in the NASCITA Study.  
In addition to the routinely collected data (basic data) fully descript in the next 
section, questions were added to allow the project to address specific areas such as 
nutrition, environment, and nurturing care.  








Some questions are already proposed during the seven well-child visits. The eCRFs 
were consequently structured in a way that will permit us to expand data collection 
and analysis in these areas in a second phase. In order to enhance the quality of the 
data, the eCRF includes consistency and range checks to prevent internal 
inconsistencies, although the continuing review of collected data is guaranteed by 
the coordinating centre and, in case of inconsistencies, pediatricians are contacted. 
The administrators of the website (the coordinating centre) can view the completed 
forms also in a graphic format that is periodically updated.  
    
B.4.1 Baseline data  
The baseline data collected during the first visit, which should happen within 45 
days of life of the newborn, parents are asked about parental medical history, 
characteristics and lifestyle, indoor and outdoor environment, and circumstances 
during pregnancy and around birth. Pregnancy and perinatal data are collected also 
through hospital discharge documents following delivery.  
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All the baseline data collected, which includes also retrospective data concerning 
information on the mother and the family and the delivery, are important to gather 
information about the broader aspect of the child's health.  
In detail, we collected subjective information concerning the family history from 
parent interviews but also chart and medical records. Past Medical History; 
medications in pregnancy and allergies from mother or father. History related to the 
current need for care or treatment were also collected.  
  
B.4.2 Follow-up and outcomes  
The primary outcomes of the study are measures of the health of the 
newborns/children from birth until (at least) the age of 6 years. Health outcomes of 
children aged 0–6 years will cover different fields including: physical development, 
mental/cognitive development, nutrition and allergies, environmental exposures, 
and preventable infectious diseases.  
The physical exams “Head to Toe assessment” (mostly objective information) includes 
information of:  
• Vital Signs (Es: pulse).  
• Inspection, Head, Ears, Eyes, Nose, Throat, and colors of lips and moistness.  
 
• Auscultation.  
• Percussion.  
• Palpation.  
• Neurological evaluation (developmental status...).  
• MSK (motor skills, some neuro).  
• Genitalia.  
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Some other Subjective information reported by parents is collected.  
Table 4 provides an overview of data sources and collection at the different follow-
up stages.  
 
 







The analysis plan for the NASCITA cohort entails the investigation of several 
exposures and outcomes to address numerous research questions. The main 
independent variables that will be tested are:  
• Maternal/paternal age. Education level. Employment. Marital status. Parental 
health status. Parental lifestyle habits (smoking, alcohol). A few examples of the 
dependent variables are Vaccination in pregnancy. Folic acid prophylaxis.  
• Birthweight. Duration of breastfeeding. Reading out loud. Sleep position. 
Overweight and obesity. Neurocognitive development. Nursery school 
attendance.  
• Prescription prevalence and appropriateness.  
A few of these variables will be tested as both independent and dependent 
variables based on the kind of analyses (e.g., reading out loud will be the dependent 
variable while testing the influence of maternal age or educational level, but will be 
considered an independent variable when possible factors influencing children’s 
development are tested).  
  
Examples of the NASCITA study’s research questions are:   
• the relationship between mothers’ age, education level, and geographic area 
(independent variables) and vaccination in pregnancy (Influenza and Tdap 
vaccines) (dependent variable);  
• the association between maternal smoking in pregnancy (independent variable) 
and birth weight (dependent variable);  
• the  relationship  between  pregnancy,  perinatal,  and 
 newborn  growth  
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characteristics and occurrence of adverse outcomes (i.e., obesity, hypertension, 
wheezing, eczema, hay fever, and asthma);  
• the relationship between parents’ educational level (independent variable) and 
duration of breastfeeding (at discharge from hospital and at 3 and 6months)  
(dependent variable);  
• the relationship between parents’ educational level (independent variable) and 
children’s weight and BMI/ percentage of overweight/obese status (dependent  
variable);   
• the association between lifestyle factors and health inequalities and the 
trajectory of health in the preschool period;   
• the association between geographical setting and nursery school attendance;   
• the association between geographical setting and quality of care in terms of 
prevalence and appropriateness of drug prescriptions.   
In all of the analyses, the effect of the geographic and environmental setting will be 
evaluated. This type of general objective, involving numerous research questions, is 
similar to the goals of two Italian cohorts, the NINFEA [Richiardi et al. 2019] and the 
PiccoliPiù [Farchi et al. 2014], as stated in their protocols.  
Some populations will be evaluated separately and included in special subgroup 
analyses such as migrant newborns, very low and low birth weight newborns.  
    
B.4.3 Statistical analysis  
Categorical variables will be summarized using proportions and associations tested 
using chi-square or Fisher’s exact test, where applicable. Continuous variables will 
be summarized using means and standard deviations for normally distributed data, 
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while skewed data will be summarized using medians. One-way ANOVA (F-value) 
will be used to test the difference of means for normally distributed continuous 
variables and the Mann-Whitney U test for skewed continuous variables. Statistical 
significance will be evaluated using a 95% confidence interval and a two-tailed p-
value of <0.05. Multivariate analyses will also be performed based on the study 
designs and outcomes to be evaluated.  
The ad-hoc analysis will also be performed based on the different research 
questions.  
  
 B.5  Organization framework  
The coordination of the NASCITA study is provided by the team of the Laboratory for 
Mother and Child Health of the Mario Negri Research Institute that integrates 
different expertise and competence with a long-standing experience in multicenter 
clinical research. The coordinating center has multiple tasks: design and wrote the 
draft of the project, create the family pediatrician network, also carry out data 
collection, storage, management, and analysis.  
A network of local contacts (contact person per area) between pediatricians has 
been set up so that each node, representative of a setting, will act as a bridge to the 
coordinating center in conducting the study. An additional group of individual 
pediatricians has been identified to act as specialists in their area of expertise, e.g., 
environment, nutrition, and neurodevelopment.  
An independent scientific committee consisting of representatives of different 
disciplines and realities (including laypeople) that monitor the development and 




B.6. Ethics and dissemination  
The study was approved by the Fondazione IRCCS Istituto Neurologico Carlo Besta’s 
Ethics Committee (6 February 2019, Verbale n.59). In the Appendix B I have 
reported the list of documents needed for the application. A consent form for 
participation has been signed by the pediatricians upon their first access to the web 
site. A paper consent form will be signed by parents at the first visit. This form 
includes the consent to data collection at each contact with the pediatrician during 
the six-year study period (first 6 years of the child’s life). The filled-in consent form 
will be stored by the pediatrician for ten years. Withdrawal from the study is 
guaranteed at any time both to pediatricians and parents. When consent is 
withdrawn, the child’s data collected up to that point will be kept in the analyses, 
but no further data will be collected. Standard procedures for the protection of 
confidential individual information will be applied according to national and 
international ethical recommendations and guidelines as well as national legal 
regulations. Data will be pseudonymized and all analyses will be conducted with 
fully anonymized data sets. A newsletter report will periodically be sent to the 
pediatricians and uploaded on the web site. During the study, different tools will be 
used to update the participating families.  
Ad-hoc information material will be created and will be disseminated to families 
through newsletters and the website. Collected data will be periodically analyzed 
according to the aims of the project, and findings reported to laypeople and the 
scientific community.  
The coordinating centre will provide the information, but the pediatricians will also 
be able to provide the families with information deriving from the cohort during 
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their visits. When the enrolled children reach the age of 6years, if not decided 
otherwise in the meantime, their files will no longer be updated but will be kept for 
another 10 years in the database.  
NASCITA proposes to be a resource for the research community, so data will be 
available to public researchers outside the NASCITA research group upon request 
for collaborative research initiatives, after approval by the scientific committee.  
  
 B.7  Application of study results  
The information gathered by the NASCITA birth cohort study will be valuable for 
child health care and public health policymaking. Information concerning the 
children will be collected at specific ages that coincide with routine contact 
moments, so findings from NASCITA that can be translated into parental advice or 
other preventive measures can directly be incorporated into routine protocols and 
reach a large group of children and their parents at once. Furthermore, study results 
on (modifiable) risk factors, disease prognosis, and medication use may also be 
relevant for family pediatricians.  
Moreover, NASCITA findings may aid policy and decision-makers, who need 
scientific evidence to develop and implement prevention and intervention 
strategies. NASCITA will progressively build on a database containing policy-relevant 
information on a broad range of determinants and health outcomes that may be 
beneficial in responding to certain public health issues. NASCITA results may also 
contribute to the evidence towards the need to build up a permanent national 




   B.8  Strengths and limitations of this study  
 
NASCITA is entirely embedded in the child health care practice foreseen by the 
National Health Service and provided by family pediatricians. Recruitment and 
follow-up coincide with routine contact moments, so broad participation and 
follow-up rates are expected. Collaboration with other cohorts is foreseen. The 
NASCITA cohort data will be linkable and integrable with other data sources, such as 
routinely collected health data or as part of future scientific collaborations. High 
participation rates would allow an appropriate description and evaluation of all the 
different national-territorial clusters. Moreover, NASCITA will provide opportunities 
to initiate new, experimental studies in subgroups of the cohort, and will contribute 
relevant information on determinants and health outcomes to policy and decision-
makers. Since the loss to follow-up is always a cause for concern in cohort studies 
and should be minimized, efforts have been made to establish a close and trust-
based relationship with all participants. These efforts involve the creation of ad-hoc 
information material, the website, and newsletters to keep in touch with the study 
participants and to apply health promotion measures within the cohort. The 
estimated 20% loss to follow-up would, in any case, lead to a sample size that is 
large enough to be able to study common childhood exposures and outcomes. With 
the parents’ consent, data on children withdrawing after 12 months of age will be 
considered in the analysis. One of the proposed benefits of distributing research 
questionnaires online, in contrast to postal methods was cost-effectiveness. 
A limit of the NASCITA study (as with any observational study) is the possibility of 
selection bias in the study population. The pediatricians recruited represent a 
cooperative sample, not a random sample, and should not be considered to be 
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representative of the population of family pediatricians. The pediatricians, for 
example, could be more sensitive to better care practices or recommendations and 
could influence the parents accordingly, promoting, for example, reading out loud 
to children. The target population of the study, however, will be the newborns (and 
their families) who are assigned to the pediatricians by the LHU based on places 
that have been freed up with those pediatricians reducing. The rising number of 
migrant patients means increasing potential language barriers in the 
communication between a healthcare practitioner and a patient who speaks a 
different language, and miscommunication may occur in healthcare settings [Singla 
et al. 2015]. Non-italian speaking parents, in particular recent immigrants, may 
decide not to participate in the study and this may create a minimal selection bias.  
  
    
 C.  Step 3: Engagement and Dissemination activities of NASCITA project  
An Engagement Strategy, essential to increase the number of participants and to 
achieve the expected number of enrollments [Lucas et al. 2013] has been 
implemented for family pediatricians and families in NASCITA project.  
Within the Engagement activities undertaken we:  
• Developed and maintained the study web-site where it is also present a space for 
feedback, questions and requests.  
• E-mail alerts and bulletins to interest list (e-mail list). The email list has been 
regularly “cleaned” to ensure that any redundant e-mail addresses are removed 
and that family pediatricians not interest in the study were removed.  
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• Social media (Facebook) have been created to communicate directly and for 
sharing information.  
• Presentations at conferences and to smaller groups (by request).  
• Conference and Journal articles.  
Within the dissemination activities that have already be taken, we:  
• Regularly provide information on a wide range of topics the families taking part 
in the studies: Family circumstances and experiences, Child health, development 
and Parenting not necessarily linked to the cohort's main topic.  
• Writing Newsletter dedicated to family pediatricians.  
• Targeted briefings to particular groups of family pediatrician  
• Presented the project at conferences and events.  
• Publication of articles.    
  
 
 C.1  The Web portal  
 A  specific  web  portal  for  the  NASCITA  cohort  study  was  developed  
(hiips://coortenascita.marionegri.it ), with reserved sections for the coordinating 
centre, registered users, and participating pediatricians. The web portal was built to 
permit data collection and to provide findings and other information during the 
study period for parents and pediatricians, also with the use of graphics for the 
analyses and data collected, based on a successful approach already reported by the 
coordinating center.[Reale et al. 2017; Bonati et al.2019; Zanetti et al. 2019]   
Selected sections of the portal have been translated into English.  
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The information for parents section contains a growing series of cards, created in 
collaboration between health professionals and parents, that provides evidence-
based information on the more common illnesses or problems in young children as 
well as answers to common questions that parents have on child care. This section 
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also contains links to useful emergency telephone numbers and useful links. In the 
pediatrician’s general area, newsletters covering the current biomedical literature 
pertinent to child cohorts are available. In Annex E, the first newsletter was 
produced.  
The website provides also a link to the public website ClinicalTrials.gov where the 
study has been registered to answer the request on data sharing (Figure 18) 
[NASCITA, 2019].  
  




    
 C.2  Family pediatricians area: The Electronic case report form  
A specific web portal for the NASCITA cohort study was developed to collect data, 
through a web-based form, and to provide findings and other information during 
the study period, also with the use of graphics on the analyses and data collection 
based on a successful approach already reported by the coordinating centre.  
To facilitate the pediatricians’ input of data for the NASCITA study, as well as 
provide fast and efficient support for any problems or data input doubts, an 
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electronic case report form (eCRF) was tested and set up (see Figure 19) and 
includes a “chat” section through which pediatricians can ask for support. The eCRF 
was structured in a way that will permit data collection to be expanded to more 
thoroughly cover the additional areas (e.g., nutrition) in a second phase. The eCRF 
includes consistency and range checks to prevent internal inconsistencies. In any 
case, data are continuously monitored and irregularities will be resolved through 
email or phone contact with the family pediatricians participants.  
In the private area, each participating pediatrician can access information such as: 
cohort documents, frequently asked questions, study protocol, and pdf versions of 
the eCRFs.  Pediatricians can also input/modify patient’s data, interactive data 
charts of his/her patients or of those of the entire cohort, including growth curves, 
and data concerning subsections of the cohort.  
    






    
Reports will be automatically generated to monitor the recruitment of pediatricians 
and children. Individual and group reports will also be created for the pediatricians 
and the scientific committee set up for the study. The administrators of the website 
(the coordinating center) will also be able to view the data in a graphic format.  
  
 C.3  Materials produced  
A range of dissemination materials have been produced to date (Figure 20 




Figure 20. Leaflets  
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Figure 22. Conference posters and press  
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 D. Step 4: Study Recruitment Data from NASCITA  
 D.1  Family pediatricians’ enrollment  
Enrollment of the family pediatricians participating in the NASCITA cohort began on 
January 1st and by September 30th, 2019.  As previously described, the pediatrician’s 
enrollment followed two phases: Initially, we have identified the representatives of each 
geographical area within the ACP members. After agreeing to participate, 
 they were asked to share the invitation to all the ACP members in their area (Figure 
24) (Figure 25).   
  


























Figure 25. Family pediatricians enrollment strategy  
  
  
On 29 November 2019, a total of 193/247 requested pediatricians accessed the 
website and made the preliminary registration. Of these 80.5% practice in the North 
of Italy, the 81.8% in the center, and 65.6% in the South of Italy.  
At the end of July 2020, the number of pediatricians that actively participate in the 
project include at least one child in the cohort is 160. The pediatricians were 







 D.2  Newborns enrollment  
Enrollment of newborns in the NASCITA cohort began on April 1st, 2019 and by 
September 30th, after six months, the number of participating pediatricians was 160 
and the number of children enrolled 2264 (Figure 26). The children enrolled (51% 
male) were distributed in the north (46%), center (21%), and south (33%). The 
number of children enrolled after 6 months represented 24% of those born in 2018 
and covered by those same pediatricians. Excluding pediatricians who had enrolled 
no children, each pediatrician recruited between 1 and 45 babies. 
  
Figure 26. Number of enrolled newborns  
 
 Date   
 D.3  Preliminary data on family   
Most of the mothers (84%) were born in Italy; the three next most common 
countries were Albania and Romania (2% each), and Morocco (1%). Family size, that 
included the newborn, ranged from 2 to 10 people, with almost half (48%) of 
families being made up of 3 people, followed by 38% made up of 4 people. Two-





















































 D.4  Preliminary data on pregnancy and labour  
Concerning the pregnancies, 86% were, while gestational diabetes (88 mothers), 
gestational hypertension (38 mothers), and preeclampsia (17 mothers) were the 
most common diseases in the remaining pregnancies. Concerning the newborns, 3% 
were born with malformations and 8% had a disease, the 3 most common of which 
were neonatal respiratory distress syndrome (21 cases), neonatal jaundice (19), and 
neonatal hypoglycemia (15).  
  
D.5 Preliminary data on some data collected during the first 6 months of life  
The following are examples of follow-up data collected during the first three routine 
visits covered in the first 6 months of the cohort. The anthropometric measures 
taken during the first visit (held within 45 days of life), showed that weight ranged 
from 500 to 7000 grams (3792 average), height 40 to 69 cm (52.5 average), and 
head circumference 26 to 43.5 cm (35.9 cm average). The second routine visit (held 
within the first 60-90 days of life) collected breastfeeding data, among other 
information. Considering the children who had already undergone this visit after 6 
months of the start of the study, about half (59%) were still being exclusively 
breastfed. Of the 41% of mothers who were no longer exclusively breastfeeding, a 
majority (59%) were giving formula milk and 41% breast and formula milk. The 
weaning data collected during the third visit (held between 5-7 months of life), 
considering the children who had undergone this visit, showed that over one half 
(56%) were being weaned, two thirds (63%) of whom in a classic manner and one 
third (37%) with the baby-led weaning method.   




IV. DISCUSSION  
Early environments and experiences have an exceptionally strong influence on brain 
architecture. The basic principles of neuroscience indicate that providing supportive 
conditions for early childhood development is more effective and less costly than 
attempting to address the consequences of early adversity later [Black et al. 2017; 
Campbell et al. 2014]. After birth, experiences play an increasingly important role in 
shaping the architecture of developing neural circuits so that they function 
optimally for each individual. Childhood development is a maturational and 
interactive process, resulting in an ordered progression of perceptual, motor, 
cognitive, language, socio-emotional, and self-regulation skills (Figure 27) [National 
Scientific Council on the Developing Child, 2007].  
  
Figure 27. Childhood development: Interconnections   
  
  
Good health (of both mother and child), good nutrition, good parenting, strong 
social supports and stimulative interaction with others outside the home all 
combine to provide the best chance of success. Since neglecting investment in any 
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one of these areas reduces the value of investment in other areas, investments to 
improve pre- and post-conception health of the future mother are a crucial input to 
early childhood development (ECD) [Black et al. 2017; Campbell et al. 2014].  
Healthy early child development, which includes the physical, social/emotional, and 
language/cognitive domains of development, strongly influences well-being, 
obesity/stunting, mental health, heart disease, competence in literacy and 
numeracy, criminality, and economic participation throughout life.  
The social determinants of health are the conditions in which people are born, 
grow, live, work and aged. These circumstances are shaped by the distribution of 
money, power and resources at global, national and local levels. The social 
determinants of health are mostly responsible for health inequities - the unfair and 
avoidable differences in health status seen within and between countries.  
(hiips://www.who.int/social_determinants/sdh_definition/en/ )  
Child health is also determining by the parenting resources (the attachment, 
guidance, and supervision accorded to children, as well as the quality of the schools, 
neighbourhoods, and hospitals surrounding them). Such early efforts promote 
schooling, reduce crime, foster workforce productivity, reduce teenage pregnancy, 
and develop healthy behaviours [Conti & Heckman 2013].  
Evidence has shown that early interventions in childhood, is far more effective than 
later remediation [Conti & Heckman 2013] and will create healthier adult 
populations and significantly reduce public health spending in the medium- and 
long-term (Marmot 2010). Demographic changes in the age structure of the 
European population are also going to have an important effect on absolute 
numbers of disease events even assuming no major changes in age-specific 
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incidence rates. The financial costs associated with treating chronic diseases are 
extremely high and given that the average age of the European population is 
increasing, chronic diseases will continue to place an important pressure on the 
national budget [Brennan et al. 2017].   
The birth cohorts are composed of individuals whose common event is birth at a 
given place and time. In these studies, data related to prenatal exposures are 
collected retrospectively. The birth cohort studies are the best methodologic 
approach to find any possible correlation affecting child health since allow the 
collection of accurate information about exposures, outcomes and several 
covariates as well as biological material which is not usually included in 
retrospective studies. The results from these studies have contributed significantly 
to our knowledge of the determinants of health during childhood, as well as the 
effects in later life. One concern is the lack of commonly acknowledged guidelines 
on the use of common measures for data collection, along with the various data 
sources used by cohorts, which lead to the extreme difficulty in merging or 
comparing data from different cohorts. This is a well-recognized issue and different 
groups are working to address it [O’Neill et al. 2019]. A huge amount of work has 
been done in this sense by the CLOSER initiatives linking all together with data from 
different UK birth cohorts. In this context, very recently they published a guide to 
the cognitive measures in five British birth Cohort studies [Moulton et al. 2020].  
With larger sample sizes, aided by the use of standard measures in the pooling of 
cohorts, and the joining of data from large epidemiological studies from other 
countries, it is possible to understand the epidemiology of diseases [Pileret al. 
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2017]. We also hope that this initiative leading the way for similar workgroup all 
around the countries, as the Life-Cycle Project aims to do  [The lifecycle, 2020).  
Observational studies based on population-based administrative data sources are 
increasingly being used to provide evidence and support quality improvement for 
pediatrics. Real-world data originating from a variety of sources are to support 
healthcare and policy decision-making [Corrao & Cantarutti 2018; Canova 2020]. 
Health surveillance (perinatal and not) in Northern Europe of the world is often of 
high quality also because of the use of record linkage between health, civil and 
administrative data [Furu et al. 2010]. And it is in this part of the world that we have 
count more birth cohorts’ studies [Pansieri et al. 2020].  
The risk factors that can affect the good child and lately adult health and can be 
analysed through these kinds of studies are categorized into two main groups: 
genetic and environmental.  
The genetic risk factors are defined as changes in the base pair sequence of the 
human genome and do not change during life. The environmental risk factors 
however are experienced throughout life of course. They vary from life events to 
exposure to lifestyle factors (diet, smoking, physical activity), to air pollution and 
medical interventions (drugs, surgery, psychological consultations, etc.)   
These environmental factors are (thought to be) modifiable and often used in 
clinical practice and intervention studies. In contrast, other environmental risk 
factors are more or less ‘fixed’, like past environmental experiences (intra-uterine 
environment; exposures at day care center, school and occupation) and macro-
environmental exposures (air pollution).  
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The systematic review that we performed at the beginning of this research shows an 
active “recent” interest. More than half of the European cohorts that we identified 
began in 2000 or later and many are still ongoing in terms of follow-up of 
participants suggesting a growing interest in longitudinal studies in particular on 
environmental factors that affecting child wellbeing. The main areas addressed by 
the cohorts were allergic diseases and environmental exposure, both of which have 
become priority study areas more recently and the numerous cohorts addressing 
environmental exposure reflect increasing attention to the negative effects of 
pollution on health. The child growth was studied more by the older cohorts, while 
obesity is a new research area. Many cohorts were designed to test a wide range of 
hypotheses, such as the Spatz cohort [Braig et al. 2017].   
Once identified the Italian and the European birth cohort’s panorama, we defined 
the general structure and the protocol of our own birth cohort: NASCITA. The 
planning and the execution of NASCITA took a lot of time and involve the 
meticulous planning  
of all its stages:   
1) the definition of the study objectives;   
2) selection of the study population;   
3) the selection of the exposures and outcomes that will be investigated;   
4) creation of instruments for data collection and measurement;   
5) development of strategies to avoid losses to follow-up;   
6) execution of a pilot study before beginning definitive data collection,   
7) the data analysis plan after completion of the follow-up.  
Considering the gap in knowledge identified by our European birth cohorts review.   
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NASCITA has been set up to have general aims with a focus on family context 
(nurturing care) and neurodevelopment. This approach addresses the identification 
of many risk factors for disorders thought to have a perinatal/early life etiology such 
as birth defects, respiratory conditions, and childhood cancer [Golding et al. 2017; 
Guyatt et al. 2015]. Genetic and environmental factors are collected and some of 
them will be added in the future when a dedicated area will be created. In this way, 
we will have the possibility to generate more hypotheses and trying to answer each 
of them.  
Clear aims and objectives should be agreed upon to facilitate direction and efficient 
methodology. Data may be used to test future hypotheses, and so as much 
information should be gathered as concisely as possible. The Aberdeen cohort 
[Lawlor et al. 2006] has been criticised for having no information on smoking in 
households, despite making detailed social observations, since this was before the 
association between maternal smoking and low birth weight had been established 
[Ong et al. 2002].  
To minimize the risk of confounding we will include as many possible questions, 
however in remain the risk of unmeasured confounding, especially when new 
relationships are investigated. To avoid this risk we will perform sensitivity analyses 
aimed to evaluate the robustness of the results to the omission of relevant factors 
in the analysis [Canova & Cantarutti 2020].  
The use of contemporary technology is hoped to improve compliance and retention 
of participants. Evidence suggests that using web-based support for epidemiological 
research can increase response rates, and improve the quality of data [Truell et al. 
2002; Golding 1990]. However, the recall accuracy efficacy using these resources is 
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still unknown [Ley et al. 2019]. To perform adequate statistical analysis, the number 
of participants should be as high as possible a drop out rats should be as low as 
possible.  Thanks to the strength collaborations with clinicians, informaticians and 
statisticians, instruments for data collection and measurement have been 
developed. Specifically a website and web-based system were set up in order to 
host the cohort, provide ongoing information to pediatricians and to families, and 
facilitate data input on the part of the pediatricians. The system was also designed 
to optimize data accuracy, minimize missing data, and permit data monitoring, 
analysis, and reporting throughout the duration of the cohort. 
To facilitate the pediatrician’s work, any document uploaded on the web based 
system has been converted and made printable. Every step from the selection of 
the clinical report form passing through the logo, the images and themes and choice 
within the dropdown menus or the single or multiple-choice buttons, were built 
with careful analysis.  
 Within the strategy to avoid losses to follow up of the participating 
pediatricians, the private area was improved with a private chat to provide instant 
support. A large amount of our work was devoted to responding the queries 
responsive that we regularly received.  Queries are mainly concerning the tasks and 
obligations (during the engagement phase) or problem on the use of the web portal 
or to doubtes on clinical question proposed in our questionnaire. All the 
pediatricians participating in NASCITA are informed of the overall status of the 
cohort through frequent email.  
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NASCITA is an ambitious project and will contribute to a better understanding of 
children’s development and health in the first year of life. A longitudinal study on 
this scale has never been done before in Italy.   
The NASCITA cohort is based on community-level pediatric practice, involving the 
family pediatricians directly. No participation fees have been allocated to the 
pediatricians, each of them. Both pediatricians and families participate voluntarily. 
With their clinical practice, pediatricians are the most frequent healthcare contact 
with patients. Pediatricians play a key role in both educating families and in 
implementing health protection and health promotion. Their involvement in child 
cohorts permits the collection of prospective, community-level data.  
  
 A.  Future directions  
Priorities for the next phase of research are:  
IMMUNISATION: This is among the most cost-effective health interventions for 
public health. In Italy, vaccination is actively offered to target population groups and 
administered free of charge by public immunisation services. In 2017, vaccinations 
against pertussis, measles-mumps-rubella (MMR), varicella and Haemophilus 
influenza type b (Hib) were added to the list of already mandatory vaccines  
(diphtheria, tetanus, hepatitis B and polio) in the national immunisation plan (NIP). 
Normally, by 12 months of age, babies should have received several vaccinations, 
including three doses of the 5-in-1 vaccination (diphtheria, tetanus, whooping 
cough, polio and Haemophilus influenzae type b (Hib)). The current rate range of 
the 5-in-1 vaccination is from 88.6% and 98.4% [D’Ancona et al. 2019].  
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INEQUALITIES: Evidence suggests that socioeconomic disadvantages in early-life can 
affect child health and have long-term effects also on adult health [Cantarutti et al. 
2017; Kuh et al. 2004]. Better identifying these inequalities will permit the 
channeling of resources where they are most needed. Collection of data at the 
national level will permit the identification of differences in health care quality, for 
example, caused also by socio-economic inequalities present between the north 
and south of Italy, differences in family behaviors that influence child health status, 
e.g. smoking or reading out loud to children, will also be examined.  
MEDICATIONS: Reviews of pediatric prescriptions in the community setting have 
quantified off-label use to reach 52 % and unlicensed use to reach 17 % [Ellul et al. 
2016]. Most drugs (75-80%) were not labeled as safe and effective for infants and 
children and off label use was the norm for these therapeutic orphans [Waller 2000;  
Conroy et al. 2000].   
LOW BIRTHWEIGHT: Low birthweight represents an important public health issue 
since it is associated with profound short term and long term consequences. [Khan 
et al. 2015; Rüdiger et al. 2019].  
A possible focus could be also put on medication use during pregnancy and its 
impact on maternal and fetal health, which is a growing public health concern. 
[Lynch et al. 2018]. The use of any medication including over-the-counter drugs, 
during pregnancy is estimated at 94%. However, studies have shown that less than 
10% of medications approved from 1980 to 2010 have sufficient evidence to 
determine fetal risks deriving from in utero exposures.  
In this field, a specific attention could be also put to medication use among women 





 B.  Strengths and weaknesses  
A strength of this thesis is the updated overview of the European birth cohorts that 
is important, and should be frequently updated, to highlight the current scenario, 
the gaps of knowledge, and to improve national and international collaboration that 
is essential to understand the epidemiology of diseases. The major weaknesses of 
this project were: highlighted the questions to be addressed, such as difficulties 
with long-term follow-up, advantages and drawbacks of different collection 
methods, funding, logistics, ethical questions and dissemination of data to the 
research community.  
A strength of NASCITA is the participation of family pediatricians, permitting the 
collection of data by those directly involved with the care of children and their 
families.  
The large representative sample of newborns from across the country, allows 
stratified trends based on socioeconomic and geographic characteristics to be 
performed.  
Among the strengths of this study is the use of standard measurements for 
anthropometric and neurocognitive parameters.  
A limit of the NASCITA cohort is that the longitudinal collection of data start after 
birth. Cohort studies that begin in pregnancy and those that begin in the 
preconception period permit to identify fetal and preconception exposures in real-
time. However, the gathering of information related to pregnant women requires 
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greater logistical planning and incurs higher costs than maternal/newborn data 
assessed at birth.  
NASCITA does not collect biological samples which has increasingly become part of 
routine data collection in similar cohorts [Bailey et al. 2017] so it will not be able to 
evaluate genetic or immunological factors, for example. Resources and efforts were 
utilized, however, to achieve the largest population size possible to have enough 
power to study relatively common child exposures and outcomes.  
In general, the set up and management of a birth cohort study requires a 
considerable amount of time and resources [Canova & Cantarutti 2020].  
Two very large studies in the UK and US have, in fact, recently been cancelled also 
due to budgetary issues [Doyle & Golding 2009; Pearson 2015]. This pragmatic 
cohort, building on existing resources to collect data, is an important attempt to 
recruit a large cohort at reduced cost. 
 
    
 V.  CONCLUSION  
For the WHO (World Health Organization) health is not only a state described by the 
absence of disease but by the achievement of a state of physical, mental and social 
well-being. From pregnancy through early childhood, all of the environments in 
which children live and learn, and the quality of their relationships with adults and 
caregivers, have a significant impact on their cognitive, emotional and social 
development. What happens to the child in the early years of life is critical for the 
child’s developmental trajectory and life time health. 
Longitudinal birth cohort studies are considered the gold standard to investigate the 
causes of disease and to establish links between risk factors and health outcomes 
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and very large birth cohort studies provide a unique opportunity to validate or 
confirm findings reported from smaller and more focused epidemiological studies. 
Their results significantly contributed to inform governments and allowed a wide 
range of policies implemented to protect and promote health in childhood including 
those directed toward early care and education.  
There is a consensus among leading scientific and political organizations that a 
national longitudinal study of a representative birth cohort, particularly one 
designed to examine disparities in health outcomes related to inequality of health 
care and sociodemographic diversity, has a unique value for major advancements in 
our understanding of how children grow into healthy, successful, and happy adults. 
NASCITA is the first Italian birth cohort built with these purposes and to explore 
how nurturing care, pediatricians and families decisions are connected with 
newborns and child health.   
Our preliminary systematic review of European birth cohort’s shows that few 
cohorts have followed in detail child development as well as neurodevelopment.  
NASCITA, moreover, is one of the rare cases in which the family pediatricians are 
directly involved and leading scientific research, considering it a pioneering 
approach.  
The European cohort list identified in the systematic review, provides a reseources 
for future work and collaboration. It will also be useful to search for connection, 
tools and to answer upcoming research questions, as on the outcomes of the recent 
COVID pandemia. The very recent COVID situation highlights the power of the 
existing longitudinal studies to understand the immediate and long-term impacts of 
the pandemic on individuals, families, households, and society. The consequences 
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of the COVID-19 pandemic for individuals, families and society will be deep and 
long-lasting. Due to the unique nature of longitudinal studies, it will also be possible 
to track the longer-term consequences and impacts for years to come, the cohorts 
that are currently recruiting patients should take into consideration this important 
aspect.   
Thanks to this unique “adventure” that enriches my knowledge in terms of research 
and methodology (bibliographic, epidemiologic and biostatistics…), and encourage 
closer cross-disciplinary collaboration (clinicians, informatics and statistical). I found 
this experience an important point of intersection between epidemiological and 
public health research.  
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Appendix A. Embase and PubMed search strategies.  
Embase  
('birth cohort'/exp OR 'birth cohort':ti,ab) AND (bulgaria:ad OR andorra:ad OR austria:ad 
OR austrian:ad OR albania:ad OR albanian:ad OR bosnia:ad OR bosnian:ad OR 
bulgarian:ad OR croatia:ad OR croatian:ad OR czechoslovakian:ad OR hungary:ad OR 
hungarian:ad OR poland:ad OR polish:ad OR kosovo:ad OR kosovian:ad OR greece:ad OR 
greek:ad OR luxembourg:ad OR norway:ad OR norwegian:ad OR iceland:ad OR 
icelanders:ad OR sweden:ad OR swedish:ad OR finland:ad OR finnish:ad OR uk:ad OR 
england:ad OR scotland:ad OR scottish:ad OR ireland:ad OR irish:ad OR denmark:ad OR 
danish:ad OR belarus:ad OR estonia:ad OR latvia:ad OR lithuania:ad OR germany:ad OR 
german:ad OR france:ad OR french:ad OR switzerland:ad OR swiss:ad OR belgium:ad OR 
belgian:ad OR dutch:ad OR netherlands:ad OR spain:ad OR spains:ad OR italy:ad OR 
italian:ad OR portugal:ad OR portuguese:ad OR slovakia:ad OR slovakian:ad OR 
slovenia:ad OR slovenian:ad OR ukraine:ad OR ukrainian:ad OR bulgaria:ff OR 
'europe'/exp OR 'european'/exp 
OR andorra:ff OR austria:ff OR austrian:ff OR albania:ff OR albanian:ff OR bosnia:ff OR 
bosnian:ff OR bulgarian:ff OR croatia:ff OR croatian:ff OR czech OR czechoslovakian:ff OR 
hungary:ff OR hungarian:ff OR poland:ff OR polish:ff OR kosovo:ff OR kosovian:ff OR 
greece:ff OR greek:ff OR luxembourg:ff OR norway:ff OR norwegian:ff OR iceland:ff OR 
icelanders:ff OR sweden:ff OR swedish:ff OR finland:ff OR finnish:ff OR uk:ff OR england:ff 
OR scotland:ff OR scottish:ff OR ireland:ff OR irish:ff OR denmark:ff OR danish:ff OR 
belarus:ff OR estonia:ff OR latvia:ff OR lithuania:ff OR germany:ff OR german:ff OR 
france:ff OR french:ff OR switzerland:ff OR swiss:ff OR belgium:ff OR belgian:ff OR dutch:ff 
OR netherlands:ff OR spain:ff OR spains:ff OR italy:ff OR italian:ff OR portugal:ff OR 
portuguese:ff OR slovakia:ff OR slovakian:ff OR slovenia:ff OR slovenian:ff OR ukraine:ff 
OR ukrainian:ff) NOT ('aged'/exp OR 'middle aged'/exp) NOT ('controlled clinical trial 
(topic)'/exp OR 'controlled clinical trial':ti,ab) NOT ('vaccination'/exp OR vaccine:ti,ab) 
NOT 'gene expression'/exp NOT ([conference review]/lim OR [editorial]/lim OR 
[review]/lim OR proceedings) AND [english]/lim AND [1-71960]/sd NOT [21-5-2019]/sd  
  
Medline (PubMed)   
(((((("birth cohort"[tiab] AND ((Poland[Affiliation] OR Germany[Affiliation] OR  
France[Affiliation] OR Switzerland[Affiliation] OR Belgium[Affiliation] OR  
Netherlands[Affiliation] OR Spain[Affiliation] OR Italy[Affiliation] OR  
Portugal[Affiliation] OR Slovakia[Affiliation] OR Slovenia[Affiliation] OR  
Ukraine[Affiliation] OR Finland[Affiliation] OR UK[Affiliation] OR Scotland[Affiliation]  
OR Ireland[Affiliation] OR Denmark[Affiliation] OR Belarus[Affiliation] OR  
Estonia[Affiliation] OR Latvia[Affiliation] OR Lithuania[Affiliation] OR  
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Poland[Affiliation] OR Kosovo[Affiliation] OR Greece[Affiliation] OR  
Luxembourg[Affiliation] OR Norway[Affiliation] OR Iceland[Affiliation] OR  
Sweden[Affiliation] OR Austria[Affiliation] OR Albania[Affiliation] OR  
Bosnia[Affiliation] OR Bulgaria[Affiliation] OR Croatia[Affiliation] OR Czech 
Republic[Affiliation] OR Hungary[Affiliation] OR Andorra[Affiliation]) AND  
("europe"[MeSH Terms] OR european[All Fields] OR "andorra"[tiab] OR  
"austria"[tiab] OR austrian[tiab] OR "albania"[tiab] OR albanian[tiab] OR "bosnia"[tiab] OR 
bosnian[tiab] OR bulgarian[tiab] OR "croatia"[tiab] OR croatian[tiab] OR "Czech 
Republic"[tiab] OR czechoslovakian[tiab] OR "hungary"[tiab] OR hungarian[tiab] OR 
"poland"[tiab] OR polish[tiab] OR  
"kosovo"[tiab] OR kosovian[tiab] OR "greece"[tiab] OR greek[tiab] OR  
"luxembourg"[tiab] OR "norway"[tiab] OR norwegian[tiab] OR "iceland"[tiab] OR 
icelanders[tiab] OR "sweden"[tiab] OR swedish[tiab] OR "finland"[tiab] OR finnish[tiab] OR 
UK[tiab] OR "england"[tiab] OR "United Kingdom"[tiab] OR "scotland"[tiab] OR 
scottish[tiab] OR "ireland"[tiab] OR irish[tiab] OR  
"denmark"[tiab] OR danish[tiab] OR "belarus"[tiab] OR "estonia"[tiab] OR  
"latvia"[tiab] OR "lithuania"[tiab] OR "germany"[tiab] OR German[tiab] OR 
"france"[tiab] OR French[tiab] OR "switzerland"[tiab] OR swiss[tiab] OR  
"belgium"[tiab] OR belgian[tiab] OR dutch[tiab] OR "netherlands"[tiab] OR "spain"[tiab] 
OR "italy"[tiab] OR Italian[tiab] OR "portugal"[tiab] OR portuguese[tiab] OR 
"slovakia"[tiab] OR slovakian[tiab] OR "slovenia"[tiab] OR Slovenian[tiab] OR 
"ukraine"[tiab] OR ukrainian[tiab]))) AND English[lang]) NOT  
("Aged"[Mesh] OR "Middle Aged"[Mesh])) NOT (((ELDERLY[Title/Abstract] OR  
ELDER[Title/Abstract]) OR GERIATRIC[Title/Abstract]) OR SENIOR[Title/Abstract]))  
NOT ("Randomized Controlled Trial"[Publication Type] OR "Randomized Controlled Trials 
as Topic"[Mesh]) NOT ("Vaccination"[Mesh] OR (vaccine[Title/Abstract] OR 
vaccine'[Title/Abstract] OR vaccine's[Title/Abstract] OR vaccine1[Title/Abstract] OR 
vaccine13[Title/Abstract] OR vaccine2014[Title/Abstract] OR  
vaccinea[Title/Abstract] OR vaccineand[Title/Abstract] OR vaccineas[Title/Abstract]  
OR vaccineassociated[Title/Abstract] OR vaccineatd[Title/Abstract] OR 
vaccinecad[Title/Abstract] OR vaccinechallenged[Title/Abstract] OR 
vaccined[Title/Abstract] OR vaccineda[Title/Abstract] OR vaccinedelivery[Title/Abstract] 
OR vaccinediluent[Title/Abstract] OR  
vaccinee[Title/Abstract] OR vaccinee'[Title/Abstract] OR vaccinee's[Title/Abstract] OR 
vaccinees[Title/Abstract] OR vaccinees'[Title/Abstract] OR vaccinefor[Title/Abstract] OR 
vaccineforme[Title/Abstract] OR vaccineformis[Title/Abstract] OR 
vaccinefrom[Title/Abstract] OR vaccinein[Title/Abstract] OR 
vaccineinduced[Title/Abstract] OR vaccinelike[Title/Abstract] OR 
vaccinelymph[Title/Abstract] OR vaccinemediated[Title/Abstract] OR 
vaccinemia[Title/Abstract] OR vaccineontology[Title/Abstract] OR 
vaccineotherapy[Title/Abstract] OR vaccinepreventable[Title/Abstract] OR 
vaccinerate[Title/Abstract] OR  
vaccines[Title/Abstract] OR vaccines'[Title/Abstract] OR vaccines''[Title/Abstract] OR 
vaccines4kids[Title/Abstract] OR vaccinesafety[Title/Abstract] OR 
vaccinesagainst[Title/Abstract] OR vaccinesan[Title/Abstract] OR 
vaccineselection[Title/Abstract] OR vaccineshoppe[Title/Abstract] OR 
vacciness[Title/Abstract] OR vaccinessummary[Title/Abstract] OR 
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vaccinesthe[Title/Abstract] OR vaccinetherapy[Title/Abstract] OR 
vaccineurin[Title/Abstract] OR vaccinex[Title/Abstract])) NOT ("Gene  
Expression"[Mesh] OR "Genes"[Mesh]) NOT (Comment[sb] OR Editorial[ptyp] OR  
Review[ptyp]) NOT proceedings[All Fields] AND English[lang])) AND (  





Appendix B. Ethics application 
 
List of the documents requested by the  Servizio Ricerca e Sviluppo Clinico Fondazione I.R.C.C.S. Istituto 
Neurologico Carlo Besta – Milano:  
a) Sinossi dello studio, versione 2.0 del 9 gennaio 2019  
b) CRF della prima Visita (See Appendix C) 
c) Informativa dello studio, versione 2.0 del 9 gennaio 2019  
d) Informativa sulla privacy e modulo di consenso informato al trattamento dei dati personali destinati ai 
genitori, versione 2.0 del 9 gennaio 2019  
 
 
 a) Sinossi dello studio, versione 2.0 del 9 gennaio 2019  
Lo sviluppo in salute dei bambini nei primi anni di vita dipende dalla “nurturing care” che garantisce un 
buono stato di salute, un’alimentazione adeguata, un atteggiamento genitoriale “responsivo”, protezione 
e sicurezza e opportunità di apprendimento precoce. I primi anni di vita sono caratterizzati da uno sviluppo 
fisico, motorio, cognitivo e relazionale estremamente rapido, che influenza in gran parte lo stato di salute e 
di benessere nel corso della vita. L’individuazione dei fattori di rischio modificabili e di fattori prognostici in 
periodi critici dell’esistenza possono contribuire allo sviluppo di strategie efficaci di prevenzione e di 
intervento. A questo riguardo è stata ideata l’iniziativa NASCITA (NAscere e creSCere in ITAlia) con lo scopo 
di monitorare lo sviluppo fisico/cognitivo/psicologico, lo stato di salute e benessere e il consumo di risorse 
sanitarie in una coorte di nuovi nati nel corso dei primi 6 anni di età e di valutare i potenziali fattori che 
possono influenzarli.  
NASCITA è un’iniziativa nazionale per la costituzione di un database/registro che raccoglierà informazioni 
(dati correnti dell’attivita’ del pediatra di famiglia) che coinvolgerà una coorte di almeno 5000 nuovi nati 
(birth cohort) a partire dal 2019, in 23 cluster geografici rappresentativi della realtà italiana.  
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L’arruolamento dei bambini avverrà nel corso della prima visita (bilancio di salute) effettuata dal pediatra 
di famiglia prevista in Italia entro i primi 45 giorni di vita.  
I dati raccolti nel corso delle 7 visite dei bilanci di salute previste nei primi 6 anni di vita dai pediatri di 
famiglia partecipanti saranno inseriti in una scheda di raccolta dati elettronica (web-based). Inoltre, 
saranno raccolti i dati riguardanti tutti i contatti tra il pediatra e il bambino/la famiglia (p.es. visite in 
ambulatorio e domiciliari, consulti telefonici, trasmissioni di informazioni relative a visite specialistiche, 
ospedalizzazioni). Saranno valutati la crescita staturo-ponderale, lo sviluppo psicomotorio, i percorsi 
educativi/di socializzazione, l’alimentazione (p.es. durata dell’allattamento al seno, età e modalità di 
svezzamento…), le vaccinazioni effettuate, eventuali malattie (in particolare le condizioni di cronicità), la 
prescrizione di farmaci, visite specialistiche ed esami diagnostici, gli accessi in Pronto Soccorso e i ricoveri 
ospedalieri. L’analisi dei dati consentirà di descrivere lo stato di salute della popolazione partecipante e 
consentirà anche di valutare p. es: eventuali associazioni tra determinanti prenatali, contesto di vita 
(ambiente), alimentazione, buone pratiche genitoriali, opportunità di apprendimento precoce e di 
socializzazione e l’incidenza di eventi avversi intesi come malattie croniche, sovrappeso/obesità, disturbi 
dello sviluppo cognitivo/psicomotorio.  
L’iniziativa sarà coordinata dal Laboratorio per la Salute Materno Infantile dell’Istituto di Ricerche 
Farmacologiche Mario Negri IRCCS, Milano, in collaborazione con l’Associazione Culturale Pediatri (ACP). 
L’iniziativa sarà monitorata da un comitato scientifico indipendente e multidisciplinare, rappresentativo di 
differenti competenze e professionalità e con il coinvolgimento di cittadini e genitori. Ai fini organizzativi, 
sono stati individuati 23 referenti allo scopo di fungere da coordinatori locali e da tramite fra i pediatri 
partecipanti e il centro di coordinamento.  
La raccolta e l’analisi dei dati da parte dei ricercatori dell’Istituto di Ricerche Farmacologiche Mario Negri 
IRCCS avverrà in forma criptata anonimizzata e i ricercatori non avranno accesso all’identità dei bambini e 
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dei genitori partecipanti. Ai genitori sarà richiesto il consenso a fornire i dati personali propri e del/della 
figlio/a per le finalità dello studio. 
 
b) CRF della prima Visita (See Appendix C) 
 
c) Informativa dello studio, versione 2.0 del 9 gennaio 2019  
 
Caro mamma, caro papà,  
siamo ricercatori e ricercatrici che lavorano nel Laboratorio per la Salute Materno Infantile dell’Istituto di 
Ricerche Farmacologiche Mario Negri IRCCS di Milano. In collaborazione con il Vostro pediatra e 
l’Associazione Culturale Pediatri (ACP) vogliamo condurre uno studio dal nome NASCITA (NAscere e 
creSCere in ITAlia) che vuole seguire nel tempo, per sei anni almeno fino all’ingresso nella scuola 
dell’obbligo, lo stato di salute di un gruppo (coorte) di bambini sin dalla nascita.  
Per questo studio abbiamo bisogno del Vostro (mamma, papà, bambino/a) aiuto.  
Questo modulo intende fornirVi tutte le informazioni necessarie affinché possiate decidere se far 
partecipare Vostro/a figlio/a a questo studio. Per qualsiasi dubbio o domanda potete, comunque, in ogni 
momento rivolgerVi al pediatra di Vs figlio/a.  
PERCHÉ?  
Per creare un registro nazionale che raccoglierà i dati di Vostro/a figlio/a insieme a quelli di moltissimi altri 
bambini allo scopo di descrivere, controllare e valutare nel tempo e nei diversi contesti di vita, lo sviluppo, 
la crescita, i percorsi educativi e di cura dei bambini, e quali fattori possono incidere sul loro benessere. 
L’analisi dei dati di questo registro permetterà di individuare alcuni fattori “critici” che possono 
compromettere la salute e il benessere dei bambini. Solo attraverso la valutazione delle informazioni 
riguardanti tanti bambini e’ possibile intraprendere azioni concrete di intervento o prevenzione.  
Grazie a questo registro sarà possibile:  
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 valutare quale è la frequenza e la durata dell’allattamento al seno, con quali tempi e modalità avviene lo 
svezzamento e quali sono i fattori associati a una maggiore attitudine all’allattamento al seno  
 descrivere la crescita (statura, peso, indice di massa corporea) dei bambini italiani, stimare quale è la 
percentuale di bambini con sovrappeso o obesità e valutare i fattori di rischio di sovrappeso/obesità  
stimare quanto sono frequenti alcune malattie nella popolazione pediatrica (per esempio bronchite 
asmatica, allergie, diabete, epilessia) e valutare quali sono i fattori che aumentano il rischio di sviluppare 
queste malattie  
 stimare quanti sono i bambini con bisogni speciali e quali sono le attenzioni e le risposte fornite nei 
differenti contesti geografici  
 valutare in che misura sono garantiti ai bambini e alle loro famiglie nei differenti contesti geografici i 
percorsi di socializzazione ed educativi  
Con questo studio, il pediatra avra’ un ulteriore strumento che gli permettera’ di evidenziare 
precocemente quelle situazioni che richiedono percorsi di cura specifici in modo da indirizzare al meglio le 
famiglie.  
CON CHI?  
Tanti nuovi nati, con la collaborazione dei genitori, sono coinvolti al momento della prima visita dal 
Pediatri di Famiglia (PdF).  
Il Vostro coinvolgimento non implica nessun impegno. Semplicemente, accettando di partecipare, alcuni 
dei dati normalmente raccolti dal Vostro pediatra saranno analizzati, insieme a quelli degli altri bambini, in 
forma criptata anonimizzata che non permetterà al ricercatore di risalire direttamente all’identità di Vostro 
figlio, se non presso il Vostro pediatra.  
QUANDO?  




In Italia: al nord, al centro e al sud; in territori costieri, di pianura e montani; nel centro e nelle periferie 
delle metropoli; in comuni urbani e in quelli rurali.  
COME?  
Lo studio non prevede di fare alcuna visita, esame o trattamento in più o differente di quanto avverrà per 
la cura di Vostro figlio/a. Le informazioni essenziali riguardanti lo sviluppo, la crescita e la salute dei 
bambini e la salute dei genitori sono quelle raccolte 
normalmente dal pediatra durante le visite e i controlli che avrà con Voi e Vostro figlio/a e che registrerà 
come di norma nella cartella clinica.  
Suo figlio/a sarà identificato/a con un codice per la trasmissione dei dati al Laboratorio per la Salute 
Materno Infantile dell’Istituto di Ricerche Farmacologiche Mario Negri IRCCS di Milano. I ricercatori non 
potranno, quindi, conoscere la vostra identità né quella di Vostro/a figlio/a.  
CON QUALI STRUMENTI?  
Partecipando a questo studio avrete la possibilità di accedere alle informazioni sulla crescita e lo sviluppo 
di Vostro/a figlio/a, collegandoVi al sito https://coortenascita.marionegri.it. Potrete consultare queste 
informazioni direttamente sul sito o scaricando e stampando un “diario” cartaceo. Solo Voi e il Vostro 
pediatra potrete generare e consultare questo “diario”. I dati da noi analizzati sono criptati e non ci e’ 
possibile risalire alle Vostre identità. Sullo stesso sito sarà disponibile materiale informativo per i genitori, 
come supporto e aiuto nella gestione dei più frequenti problemi di salute e suggerimenti su buone pratiche 
per una sana crescita.  
Sarete periodicamente aggiornati dal Vostro pediatra e/o attraverso il sito sull’andamento dello studio e 
sui risultati ottenuti.  
Se accettate di partecipare, Vi chiediamo gentilmente di acconsentire al trattamento dei dati personali 
Vostri e di Vostro/a figlio/a, leggendo l’informativa che il pediatra Vi ha consegnato e firmando il modulo di 
consenso. La partecipazione allo studio è volontaria, il rifiuto non compromette in nessun modo la qualita’ 
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delle cure fornite dal vostro pediatra. E in quasiasi momento potrete ritirarVi. Non saranno raccolti 
ulteriori dati che Vi riguardano, ferma restando l'utilizzazione di quelli eventualmente già raccolti per 
conseguire, senza alterarli, i risultati della ricerca. 
 
 
d) Informativa sulla privacy e modulo di consenso informato al trattamento dei dati personali destinati 
ai genitori, versione 2.0 del 9 gennaio 2019  
 
 INFORMATIVA PER IL TRATTAMENTO DEI DATI PERSONALI  
Titolo dello studio: Coorte NASCITA- NAscere e creSCere in ITALIA (anche lo “Studio”)  
Promotore:  
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Giuseppe La Masa 19, 20156, Milano; (anche 
“Promotore”) 
Titolare e Responsabile della Protezione dei dati  
Il Promotore che ha commissionato lo Studio (inclusi suoi partner di ricerca, designati e rappresentanti che 
collaborano allo Studio) e il pediatra di Suo/a figlio/a, in qualità di Titolari del Trattamento, ciascuno per gli 
ambiti di propria competenza e in accordo alle responsabilità previste dalle norme di Buona Pratica Clinica 
(D.L. 211/2003), dal Regolamento UE 2016/679 del Parlamento e del Consiglio Europeo relativo alla 
protezione delle persone fisiche con riguardo al trattamento dei dati personali, nonché alla libera 
circolazione di tali dati (di seguito GDPR), dall’Autorizzazione generale n.9/2016 al trattamento dei dati 
personali effettuato a scopi di ricerca scientifica del 15 dicembre 2016, e successive modifiche, tratteranno 
i dati personali, Suoi e di suo figlio/a, soltanto nella misura in cui sono indispensabili in relazione 
all’obiettivo dello Studio e per le finalità di seguito indicate.  
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La informiamo che i Titolari, ai sensi dell’articolo 37 del GDPR EU 2016/679, hanno proceduto ad 
individuare e nominare il Responsabile della Protezione dei dati (anche “Data Protection Officer” o “DPO”):  
Daniele Gervasio, Via D. Piccinini 2, Cap 24122, Bergamo. Tel: 035-3889611  
Categorie di dati oggetto del trattamento  
Il presente trattamento avrà ad oggetto i Suoi dati personali e quelli di Suo figlio/a, di seguito meglio 
specificati:  
a) Dati identificativi: Nome, Cognome, Data e Comune di Nascita di Suo figlio/a e dei genitori, Comune di 
residenza del nucleo famigliare.  
b) Dati particolari ex art. 9 GDPR relativi a:  
- Andamento della gravidanza (tipo di concepimento, problemi di salute della mamma insorti durante la 
gravidanza);  
- Parto (tipo di parto, età gestazionale, peso alla nascita, lunghezza, circonferenza cranica, punteggio 
APGAR);  
- Andamento dell’accrescimento (peso, altezza) e dello sviluppo neurologico, psicomotorio e relazione 
del/della bambino/a;  
- Tipo di allattamento e alimentazione del bambino; Malattie acute e croniche del/della bambino/a, 
prescrizione di farmaci ed eventuali ricoveri o accessi in Pronto Soccorso;  
- Eventuali malattie croniche ed ereditarie presenti in famiglia (genitori, nonni);  
 
Tutti i dati sopra citati, sono quelli raccolti normalmente dal pediatra nel corso delle visite e registrati nella 
cartella clinica e da lui/lei utilizzati “per l’esercizio dell’attività di prevenzione, diagnosi e cura dello stato di 
salute del bambino/a, nonché per gli adempimenti di legge, per gli adempimenti previsti dalla normativa in 
tema di servizio sanitario nazionale e per finalità gestionali e statistiche”, e per cui Lei ha già espresso il 
consenso al trattamento.  
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Nel caso in cui i ricercatori decidessero di avviare studi specifici, le potrebbero essere richieste altre 
informazioni. In tal caso, la Sua partecipazione resterà volontaria e le sarà sottoposto un ulteriore modulo 
di consenso informato.  
Finalità del trattamento  
I dati sopra descritti verranno trattati per consentire lo svolgimento dello Studio in parola e di tutte le 
relative operazioni ed attività strettamente connesse allo stesso (intendendosi – a titolo esemplificativo e 
non esaustivo, le analisi statistiche con lo scopo di valutare l’influenza di determinanti ambientali, sociali, 
famigliari, sullo sviluppo e sullo stato di salute del bambino.  
Base giuridica del trattamento  
Il consenso informato costituisce la base giuridica per il trattamento dei Suoi dati e di Suo/a figlio/a per gli 
scopi descritti nella scheda informativa. In assenza di consenso firmato non potremo utilizzare i Suoi dati e 
quelli di Suo/a figlio/a per la conduzione e le analisi dello Studio.  
Potrà interrompere la partecipazione di Suo/a figlio/a in qualsiasi momento e senza fornire alcuna 
motivazione; in tal caso, i Vostri dati verranno trattati come descritto nella scheda informativa dello 
Studio. A seguito di ciò, non saranno raccolti ulteriori dati che Vi riguardano, ferma restando l'utilizzazione 
di quelli eventualmente già raccolti per conseguire, senza alterarli, i risultati della ricerca.  
Natura del conferimento dei dati  
La partecipazione allo Studio avviene su base volontaria, pertanto, il conferimento dei dati personali è 
assolutamente volontario, nel senso che Lei può decidere di non conferire i Suoi dati personali e quelli di 
Suo figlio/a, quindi, di non partecipare allo Studio.  
Modalità di Trattamento dei dati  
Le finalità sopra indicate prevedono lo svolgimento del trattamento dei dati personali mediante strumenti 
manuali e informatici con logiche strettamente correlate alle finalità stesse e, comunque, in modo da 
garantire la sicurezza e la riservatezza dei dati stessi.  
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I dati raccolti per i fini dello Studio verranno gestiti in forma codificata: Suo figlio/a sarà identificato/a con 
un codice che non permetterà di risalire direttamente alla Sua identità, se non presso il Suo pediatra. I 
ricercatori avranno a disposizione dati contraddistinti unicamente dal codice segreto che impedisce loro 
qualsiasi possibilità di associare i dati delle indagini scientifiche con la Vostra identità.  
I dati che La riguardano, raccolti nel corso dello Studio, ad eccezione del Suo nominativo e di quello di Suo 
figlio/a, saranno trasmessi al Promotore e dallo Stesso registrati, elaborati e conservati.  
Soltanto il pediatra, potrà collegare questo codice ai vostri nominativi quando necessario.  
Ambito di comunicazione dei dati  
La diffusione dei dati scientifici risultanti dalle analisi dei dati dello Studio, potrà avvenire solo in forma 
anonima e per sole finalità scientifiche. In pratica, i risultati delle ricerche scientifiche, potranno essere 
presentati in forma aggregata nell’ambito di Convegni o pubblicati su riviste specializzate senza mai 
permettere la precisa identificazione dei singoli pazienti.  
I Suoi dati personali potranno essere trasferiti a Centri esterni per avvalersi della collaborazione di soggetti 
terzi per le finalità previste dal protocollo, espressamente designati dai Titolari quali “Responsabili del 
trattamento”.  
Potrà conoscere l’elenco aggiornato dei Responsabili del Trattamento, inviando una comunicazione ai 
riferimenti sopra riportati.  
Trasferimento dei dati ad un Paese terzo o a un’organizzazione internazionale  
Sebbene lo Studio non preveda che i Suoi dati personali codificati vengano trasferiti e trattati in Paesi al di 
fuori dell’Area Economica Europea (European Economic Area (EEA)), deve sapere che qualora ciò si 
dovesse rendere necessario, per ragioni tecniche non prevedibili fin da subito, avverrà esclusivamente per 
finalità di archiviazione/memorizzazione dei dati presso data centers. In tal caso, saranno comunque 
adottate tutte le misure di sicurezza appropriate per salvaguardare i Suoi diritti in materia di riservatezza 
dei dati.  
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Politica in materia di conservazione dei dati personali  
I dati personali raccolti nell’ambito di questo Studio verranno conservati presso il pediatra, e il Promotore, 
per un periodo minimo di 10 anni dopo la conclusione dello Studio o per un periodo più lungo, se 
necessario, in base ad ulteriori requisiti di legge.  
Diritti dell’Interessato:  
Diritto di accesso ai dati  
Può chiedere di consultare le informazioni che sono state raccolte su Suo figlio/a o su di Lei. Tuttavia, per 
salvaguardare l’integrità scientifica dello Studio, potrebbe non essere possibile accedere ad alcuni dati 
prima della conclusione dello Studio stesso. 
Diritto di rettifica ai dati  
Può richiedere la modifica dei dati che vi riguardano, qualora fossero errati o incompleti. Durante la 
valutazione di tale richiesta, ha il diritto di limitare il trattamento dei dati che La riguardano.  
Diritto di portabilità dei dati  
Può richiedere il trasferimento dei dati che La riguardano a Lei stesso o a qualcun altro in un formato 
comunemente utilizzato (cartaceo o elettronico).  
Diritto di cancellazione dei dati  
Può ritirare il consenso in qualsiasi momento senza darne motivazione alcuna. Può ritirare il consenso per 
il trattamento dello Studio e/o il follow up successivo, anche senza ritirare il consenso per il trattamento 
dei dati. Qualora cambiasse idea sul trattamento dei Suoi dati e di quelli di suo figlio/a, non sarà possibile 
rimuovere le informazioni personali già elaborate per lo Studio prima del Suo ritiro (coperte dal consenso 
originale). In seguito, al ritiro del consenso al trattamento dei Suoi dati non verrebbero acquisite ulteriori 
informazioni che La riguardano.  
Diritto di reclamo  
Può presentare un reclamo presso l’autorità incaricata della protezione dei dati:  
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Garante della privacy, E-mail: garante@garanteprivacy.it, Sito web: http://www.garanteprivacy.it/  
In merito all’esercizio di tali diritti, potrà rivolgersi direttamente al Suo pediatra o, per il suo tramite, al 
























Consenso al trattamento dei dati personali  
ai sensi del GDPR UE 2016/679  
Preso atto dell’informativa di cui all’art. 13 del GDPR UE 2016/679, il 
sottoscritto______________________, nato a_________________, il__________, in qualità di:  
Interessato e:  
Esercente la potestà di Genitore del minore (nome e cognome)______________________  
nato/a a______________________ il____________  
residente a ______________________ in Via ______________________  
□ Congiuntamente all’altro genitore (nome e cognome) ______________________  
nato a __________________ il________  
residente a______________________ in via___________________  
 Presente  
 Assente, ma è INFORMATO e AUTORIZZA a procedere per il minore  
 
□ Disgiuntamente dall’altro genitore in forza del seguente Provvedimento_____________  
n__________________ in data __________________ repertorio/registro __________________  
Autorità __________________ di __________________  
□ Genitore unico  
□ Dà il proprio consenso □ Nega il proprio consenso  
al trattamento dei dati del minore per le finalità relative allo studio osservazionale sopra citato  
□ Dà il proprio consenso □ Nega il proprio consenso  
al trattamento dei propri dati per le finalità relative allo studio osservazionale sopra citato  





Appendix C.  Data collected in the first visit    
1°  -  ANAGRAFICA DEL BAMBINO  
  
 Nome ……………………………………………………………………..    
  
Cognome …………………………………………………………  
  
Sesso     □ M     □  F  
Data di nascita                  
   giorno  mese  anno  
  
Regione di nascita ………… ………… (lista)  
 Provincia di nascita ………… ………… (lista)    
Comune di nascita  ………… ………… (lista)  
  
Regione di residenza ………… ………… ………… (lista)  
Provincia di residenza ………… ………… ………… (lista)   
Comune di residenza ………… ………… (lista)   
    
2°  -   NUCLEO FAMIGLIARE  
  
1. Tipologia del nucleo famigliare  □  eterogenitoriale  
   □  omogenitoriale  
  
2. Componenti del nucleo famigliare (compreso il bambino)  Numero  
  
  
3. Il bambino vive con entrambi i genitori?  □ SI  □  NO     
  
4. Figlio unico?  □ SI  □  NO             




Se NO, Specificare il numero di figli, fratelli che vivono con il bambino (compreso il 
bambino)        
  
 Se NO, i fratelli sono portatori di malattie croniche?  □ SI  □  NO     
  
   Se SI, quali malattie          □ Diabete  
   □ Epilessia  
   □ Asma   
   □ Ipertensione   
   □ Altro, specificare  
………….… (ELENCO)   
  
5. Animali domestici?         □ SI  □  NO       
   Se SI, specificare  □ Cane  
     □ Gatto  
     □ Coniglio  





    
-   
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 3°   ANAGRAFICA della MADRE  
  
 
Data di nascita                  
   giorno  mese  anno  
6. E’ nata in Italia?  □ SI  □  NO     
Se NO, specificare nazione …………………………….………….………… (lista)  
 Se SI,  Regione di nascita  ………… ………… ………… (lista)  
   Provincia di nascita ………… ………… ………… (lista)    
   Comune di nascita  ………… ………… ………… (lista)      
  
7. Mamma nata in Italia da famiglia straniera? □ SI  □  NO     
  
8. Durante la gravidanza, la residenza era la stessa di quella registrata per il 
neonato? □ SI  □  NO     
 Se NO: La residenza durante la gravidanza era in Italia?  □ SI  □  NO       
   Se NO, Nazione …………………..   
   Se SI, Regione di residenza ………… ………… ………… (lista)  
     Provincia di residenza ………… ………… ………… (lista)    
     Comune di residenza ………… ………… (lista)   
9. Primo Figlio   □ SI  □  NO     
10. Stato civile  □ Nubile   
   □ Coniugata/Unita  
Civilmente  
   □ Separata/Divorziata  
   □ Convivente  
   □ Vedova  
  
11. Titolo di studio conseguito  □ Scuola Primaria  
(elementare)  
   □ Scuola Secondaria di I  
grado (medie)  
   □ Scuola Secondaria di II  
grado (superiori)  
   □ Laurea (università)  
   □ Nessuno  
  
12. Condizione professionale  □ Studentessa  
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   □ Occupata   
   □ Disoccupata  
   □ Casalinga   
  
 Se occupata, specificare posizione professionale  □ Libero professionista  
   □ Imprenditrice  
  □ Impiegata   □ Dirigente   
   □ Operaia   
   □ Insegnante/educatrice  





13. Soffre di malattie croniche?  □ SI  □  NO     
 Se SI, specificare    □ Diabete  
   □ Epilessia  
   □ Asma   
   □ Ipertensione   
   □ Altro, specificare ……….….……    
  
14. Soffre di atopia?   □ SI  □  NO     
 Se SI, specificare    □ Asma  
   □ Rinite allergica   
   □ Eczema   
   □ Altro specificare ……….…………   
         
15. Vi sono malattie croniche/ereditarie in famiglia (genitori, fratelli/sorelle, 
materni)?     □ SI  □   
 NO   □ Non note     
   Se SI,  specificare ……….……………………     
    
    
 4°   ANAGRAFICA del PADRE  
  
Data di nascita                  
   giorno  mese  anno  
  
16. E’ nato in Italia?    □ SI  □  NO     
Se NO, specificare nazione ………… ………… ………… (lista)  
-   
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 Se SI,  Regione di nascita  ………… ………… ………… (lista)  
   Provincia di nascita ………… ………… ………… (lista)    
   Comune di nascita  ………… ………… ………… (lista)          
  
  
17. Stato civile  □ Celibe   
   □ Coniugato/Unito  
Civilmente  
   □ Separato/Divorziato  
   □ Convivente  
   □ Vedovo  
  
18. Titolo di studio conseguito  □ Scuola Primaria (elementare)  
   □ Scuola Secondaria di I  
grado (medie)  
   □ Scuola Secondaria di II  
grado (superiori)  
   □ Laurea (università)  
   □ Nessuno  
  
19. Condizione professionale  □ Studente  
   □ Occupato   
   □ Disoccupato  
   □ Pensionato  
   □ Casalingo   
  
 Se occupato, specificare posizione professionale  □ Libero professionista  
   □ Imprenditore  
   □ Impiegato  
   □ Dirigente   
   □ Operaio   
   □ Insegnante/educatore  
   □ Altro  
  
  
Compilare le domande 19-20-21 solo se il tipo di nucleo famigliare è eterogenitoriale   
  
20. Soffre di malattie croniche?    □ SI  □  NO     
 Se SI, specificare    □ Diabete  
   □ Epilessia  
   □ Asma   
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   □ Ipertensione   
   □ Altro, specificare  
 ……….….…… (ELENCO)     
21. Soffre di atopia?   □ SI  □  NO     
 Se SI, specificare    □ Asma  
   □ Rinite allergica   
   □ Eczema   
   □ Altro specificare  
……….…………   
         
22. Vi sono malattie croniche/ereditarie in famiglia (genitori, fratelli/sorelle, 
paterni)?     □ SI  □  NO 
    □ Non note     












23. Concepimento naturale?   □ SI  □  NO     
  
  
24. Gravidanza con decorso fisiologico?   □ SI  □  NO    
Se NO, specificare la patologia intercorsa durante la gravidanza  □ Diabete gravidico  
     □ Ipertensione gravidica  
     □ Pre-eclampsia  
     □ Altro, specificare  
……………   
    
25. Assunzione di acido folico?   □ SI  □  NO    Se SI, specificare il periodo 
di assunzione:    
□ almeno 1 mese prima della gravidanza e per tutto il 
I° trimestre  
-   
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□ almeno 1 mese prima della gravidanza e per tutta la 
gravidanza  
□ solo nel I° trimestre (non prima della gravidanza) □ 
a partire del I° trimestre e oltre  
  
26. Assunzione continuata di farmaci (non integratori) con modalità 
croniche/subcroniche (per oltre 3 settimane in modo continuativo), 
prescritti dal medico durante la gravidanza?   □ SI  □  NO     
   Se SI, quali ……….…………… (lista ATC)       
27. E’ stata vaccinata in gravidanza?  □ SI  □  NO    
 Se SI, specificare la vaccinazione  □ Antinfluenzale  
   □ dTpa (Difterite, tetano, pertosse)   sett. gestazione   
   
   □ Altro, specificare ……………………………………..  
  
28. Fumatrice (sigarette)?  □ SI      
   □ NO, Mai fumato  
   □ Ho smesso prima della gravidanza  
   □ Non risponde  
  
 Se SI, durante la gravidanza?  □ Occasionalmente  
   □ Giornalmente  
  
 Se giornalmente, quanto?  □ Poco ( 10/die)  
   □ Moderato ( 11-19/die)  
   □ Tanto (1 pacchetto/die)  
  
29. Assunzione di Alcol?  □ SI      
   □ NO, Astemia  
   □ Ho smesso prima della gravidanza  
   □ Non risponde  
  
Se SI, durante la gravidanza?  
   □ Occasionalmente  
   □ Giornalmente  
  
 Se giornalmente, quanto?   Numero di unità alcoliche al giorno      
  





30. Peso inizio (kg)        Peso fine (kg) 
       
Aumento ponderale percentuale durante la gravidanza  (kg)  _______________  
(calcolato in automatico)    
  
31. Altezza (cm)   
BMI (indice di massa corporea) a inizio gravidanza _______________ (calcolato in 
automatico)  
BMI (indice di massa corporea) a fine gravidanza _______________ (calcolato in automatico)  
  
  
GRAFICO IN AUTOMATICO  
  
32. Gravidanze precedenti?    □ SI  □  NO    
      Se SI, specificare numero di gravidanze      
  
 
33. Durante la gravidanza ha mai letto un libro ad alta voce?  □ Mai     
        □ 1-2 volte  
        □ Più di 2 volte  
  
Sottopeso = <18,5  
Normopeso = tra 18,5 e 24,9  
Sovrappeso = tra 25,0 e 29,9  
Obeso = ≥ 30  
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34. Durante la gravidanza hai praticato dell’ascolto musicale rivolto al tuo bambino?   □  
 Mai      
                □  
1-2 volte  
               □  
Più di 2 volte  




Parto   
  
35. Età gestazionale alla nascita (settimane)             
  
36. Ha partorito in ospedale?  □ SI  □  NO   
37. Parto singolo?   □ SI  □  NO       
   Se NO, specificare il numero di nati    
  
38. Modalità del parto:  □ Spontaneo  
   □ Cesareo  
   □ Forcipe  
   □ Ventosa  
  
39. Subito dopo il parto c’è stato contatto pelle a pelle “mamma-
neonato”? □ SI  □  NO   
  




6°  -  ANAMNESI NEO-PERINATALE  
  
40. Punteggio APGAR      (valori da 0 a 10)  1’     5’  
     
41. Peso alla nascita (gr)     
42. Lunghezza (cm)    
43. Circonferenza cranica (cm)    
44. Rianimazione cardiopolmonare?   □ SI  □ NO  
45. Malformazioni?  □ SI  □ NO      
   Se SI, specificare la malformazione …………………….  (ELENCO)        
  
46. Patologia neonatale? □ SI  □ NO      
   Se SI, specificare la patologia …………………….  (ELENCO)        
  
47. Ricovero in Unità Operativa di Neonatologia (Nido)**?   □ SI  □ 
NO     
  
48. Ricovero in Unità di Terapia Intensiva Neonatale (UTIN)?  □ SI  □ NO     
  Se SI, specificare il numero giorni di ricovero       
   Diagnosi alla dimissione …………………….  (ELENCO)       
  
49. Durante la degenza in ospedale* (*nascita-dimissione)   
 al neonato è stato somministrato:     □ Latte materno  
     □ Latte artificiale  
     □ Acqua   
     □ Acqua zuccherata  
     □ Tè  
    □ Tisane     □ Succhi  
  
50. Alla dimissione il bambino era allattato ESCLUSIVAMENTE al seno?   □ 




  ** ci riferiamo a quelle situazioni che 
hanno avuto come esito un ricovero  
   prolungato per problemi neonatali, o un  
ricovero in reparto di Unità Operativa di  
   Neonatologia (Nido) dopo la dimissione  
dalla Terapia Intensiva neonatale. Non ci  
riferiamo al normale transito in questa 164.  
unità ospedaliera in caso di un bambino 
sano.  
T1  ̶    PRIMA VISITA  PEDIATRA-BAMBINO  
Nel primo mese di vita (1-45 giorni)  
  
51. Data della  visita                  
   giorno  mese  anno  
  
      
52. Alla dimissione al bambino è stata prescritta qualche terapia farmacologica? □ SI  □  
NO  
Se SI, specificare ………………………………… (LISTA ATC)  
  
CONTROLLO AUXOLOGICO   
  
VALUTAZIONE ANTROPOMETRICA                                     (con i valori COMPARE IL 
GRAFICO PERCENTILI)  
  
53. Peso (gr)     _______________  
(calcolato in automatico)  
54. Lunghezza (cm)    _______________  
(calcolato in automatico)  
55. Circonferenza cranica (cm)    _______________  
(calcolato in automatico)  
  
BMI (indice di massa corporea) _______________ (calcolato in automatico)  
  
ALIMENTAZIONE E SONNO  
  
56. Attualmente il bambino riceve esclusivamente* latte materno?  
   □ SI  □  NO      
 Se NO, specificare    □ Artificiale    □ Misto     
 Il latte artificiale quando è stato introdotto? (giorni del bambino)    
 
 
   
  
57. Nelle ultime 24 ore, il bambino ha assunto altre bevande oltre al latte?  
   □ SI  □  NO      
 Se SI, specificare    □ Acqua   
     □ Acqua zuccherata  
     □ Tè  
     □ Tisane  
     □ Succhi  
  





ESAME OBIETTIVO   
                      (campo di testo 
libero)   
59. Fontanella anteriore normale?   □ SI  □  NO    Se NO, specificare:  
…………………….  
  
60. Cute Normale?   □ SI  □  NO    Se NO, specificare:  
…………………….    
  
61. Cuore normale?  □ SI  □  NO      Se NO, specificare:  
…………………….    
  
62. Torace normale?   □ SI  □  NO      Se NO, specificare:  
…………………….  
  
63. Organi ipocondriaci normali?   □ SI  □  NO    Se NO, specificare:  
…………………….    
  
64. Genitali normali?    □ SI  □  NO     Se NO, specificare:  
 …………………….      
  
65. Alvo normale?  □ SI  □  NO     Se NO, specificare:  
…………………….    
  
66. Colore delle feci normale?  □ SI  □  NO     Se NO, specificare:  
…………………….    
  
67. Valutazione ortopedica normale? □ SI  □  NO       
  Se NO, specificare:   □ Piede torto congenito    
 □ Piede talo valgo  
     □ Metatarso varo riducibile  
     □ Metatarso varo non riducibile   
     □ Frattura della clavicola   
     □ Lesione del plesso brachiale   
     □ Displasia evolutiva dell’anca (dopo aver eseguito la manovra di  
Ortolani-Barlow)  
     □ Plagiocefalia   
     □ Torcicollo   
  
PROCEDURE CLINICO-STRUMENTALI E TERAPEUTICHE  
  
68. Profilassi vitamina K alla nascita?    □ SI  □  NO      
 
178.  
 Se SI, ancora in corso?  □ SI  □  NO      
69. Profilassi vitamina D in corso?    □ SI  □  NO    
 Se NO, è stata prescritta in questa visita?  □ SI  □  NO        
70. Altre supplementazioni:  □ SI  □  NO    
 Se SI  □ Ferro      
    □ Luteina  
   □ Multivitaminico  
   □ Altro, specificare ______________________  
  
71. Screening neonatale esteso effettuato?   □ SI  □  NO     
72. Otoemissioni (verifica esecuzione)?  □ SI  □  NO     
73. Riflesso rosso normale?   □ SI  □  NO    
Se NO, specificare  □ Cataratta parziale    □ 
Cataratta totale   
   □ Retinoblastoma  
VALUTAZIONE DELLO SVILUPPO NEUROLOGICO E PSICOMOTORIO   
  
MOTRICITÀ   
  
74. Movimenti ricchi, variabili, fluidi, compreso mani e piedi  □ Normale  □  Da rivalutare a breve  
 □  Patologico    
75. Controllo del capo su tronco (in braccio, prono, alla trazione)   □ Normale  □  Da rivalutare a  
 breve   □  Patologico  
 76. Arti sulla linea mediana (mani alla bocca)      




□ Normale  □  Da rivalutare a  
 77. Sguardo (fissa e segue il volto o un oggetto)       
 breve   □  Patologico  
□ Normale  □  Da rivalutare a  
 78. Ascolto (reagisce, presta attenzione e si orienta ai suoni)    
 breve   □  Patologico  
□ Normale  □  Da rivalutare a  
 79. Mimica (qualità e variabilità espressiva)       
 breve   □  Patologico  
□ Normale  □  Da rivalutare a  
80. Pianto e consolabilità (si calma con voce, contenimento, suzione)  □ Normale  □  Da rivalutare a  






81. Nel corso di questa visita al bambino è stato prescritto qualcosa?      □ SI    □  NO, sta 
bene  
    
    
    
   Suggerito 
    
Se SI, specificare  □  Terapia farmacologica:  
  □  
    farmaco (ATC)  ………………………………………………….. +  
    motivo (ICD)  …………………………………………………….. + 
    
  □  Visita specialistica, specificare ………………………………………..…..  
  □   
  □  Esami di laboratorio   
  □   
  □ Esami diagnostici   
□ Ecografia, specificare sede  
 
 …………………………………………………  
□ Radiografia, specificare sede  
□  
 ………………………………………………  
□ Tac, specificare sede  
□  
 ……………………………………………………..……  
□ Risonanza, specificare sede  
□  
 …………………………………………………  □  
  □ Elettrocardiogramma    □  
  □ Elettroencefalogramma    □  
  □ Polisonnografia    
□ Altro, specificare  
□  







Appendix D. Data collected in the second visit  
T2  ̶    SECONDA VISITA   






82. Data della  visita                     
   giorno  mese  anno  
  
  
CONTROLLO AUXOLOGICO  VALUTAZIONE ANTROPOMETRICA                       
                  
    (con i valori COMPARE IL  
GRAFICO PERCENTILI)  
83. Peso (gr)     _______________  
(calcolato in automatico)  
84. Lunghezza (cm)    _______________  
(calcolato in automatico)  
85. Circonferenza cranica (cm)   _______________  
(calcolato in automatico)  
  
BMI (indice di massa corporea) _______ (calcolato 
in automatico)  
  
  
ALIMENTAZIONE E SONNO  
  
86. Attualmente il bambino riceve esclusivamente* latte materno?    □ SI  □  NO   Se NO, 
specificare    □ Artificiale    □ Misto  
  
87. Nelle ultime 24 ore, il bambino ha assunto altre bevande oltre al latte?   □ SI  □   
 NO    
   Se SI, specificare    □ Acqua  
     □ Acqua zuccherata  
     □ Tè  




88. Postura abituale nel sonno  □ Prono    □ Supino    □ Di fianco     
    
   
89. Dove dorme in prevalenza?  □ Culla    □ “Next to me”    □ Lettone    
  
90. Presenza di disturbi del sonno?  □ SI  □  NO   Se SI  □ Difficoltà ad addormentarsi  
     □ Risvegli frequenti  
     □ Dorme poco  
     □ Altro, specificare ______________________  
  
91. Il genitore riporta coliche?  □ SI  □  NO  
92. Il genitore riporta altri disturbi?  □ SI  □  NO  





ESAME OBIETTIVO     
      
       (campo di testo libero)  
      
93.  Fontanella anteriore normale?  
____________________  
  
 □ SI  □  NO    Se NO, specificare:  
94.  Cute normale?  
____________________  
  
□ SI  □  NO    Se NO, specificare:  
95.  Orofaringe normale?   
____________________  
  
□ SI  □  NO    Se NO, specificare:  
96.  Cuore normale? 
____________________  
  
□ SI  □  NO    Se NO, specificare:  
97.  Torace normale?   
____________________  
  
□ SI  □  NO    Se NO, specificare:  
98.  Addome normale?   
____________________  
  
□ SI  □  NO    Se NO, specificare:  
99.  Ombelico nomale?    □ SI  □  NO    Se NO, specificare:  
 ____________________  
  
   
100. Apparato genitale normale?    
____________________  
  
□ SI  □  NO    Se NO, specificare:  
TOOLTIP  
* il consumo di latte umano 
senza aggiunta di supplementi  
di alcun genere, fatta 
eccezione per vitamine, 
minerali e farmaci.  
 
182.  
        
VALUTAZIONE DELLO SVILUPPO NEUROLOGICO E PSICOMOTORIO   
   
 CONTROLLO DELL’UDITO  
      
      
101. Il bambino gira gli occhi e/o la testa verso la fonte di un suono? □ SI  □  NO    □  Da 
rivalutare a breve    
  
102. Cambia espressione al suono di una campanella o di un sonaglio fatti tintinnare al di 
fuori del   
campo visivo?        □ SI  □  NO   □  Da rivalutare a breve  
  
MOTRICITÀ      
      
 
    
   Patologico  
Normale  Da rivalutare a breve 
103. Si muove bene e in modo simmetrico  □   □   
  
 (movimenti ricchi, variabili, fluidi, compreso mani e piedi)    □      
 
104. Controllo assiale capo e tronco  □   □   
  
 (in braccio, prono, alla trazione)    □    
 
105. Arti sulla linea mediana  □   □   
  
(piedi e mani)  
  
□     
106. Sostegno sugli arti superiori – Da prono apre le mani  □   □   
  □  (iniziale)   
     
107. Attività occhio-mano-bocca  □   □   
  □     
(si guarda le mani, le porta in bocca, tocca gli oggetti)  
    
  
RELAZIONE  
    
108. Sguardo (fissa e segue il volto o un oggetto)   □   □   
  □     
109. Ascolto (reagisce, presta attenzione e si orienta ai suoni)  □   □   
  □     
 
183.  
110. Mimica (espressivo, sorride e poi ride, vocalizza)   □   □   
  □     
111. Pianto e consolabilità (si calma con voce, contenimento, suzione)  □   □   




PROCEDURE CLINICO-STRUMENTALI E TERAPEUTICHE  
  
112. Profilassi vitaminica in corso:  Vitamina D  □ SI  □  NO    
     Vitamina K  □ SI  □  NO      
113. Altre supplementazioni (vitamine o integratori)?   □ SI  □  NO     
   Se SI:  □ Ferro  
   □ Luteina  
   □ Multivitaminico  
   □ Altro, specificare ______________________  
  
114. Riflesso rosso normale?   □ SI  □  NO    Se NO, specificare:  
____________________  
  
115. Manovra di Ortolani-Barlow?   □ Positiva      □  Negativa  
  
116. Ecografia delle anche effettuata?  □ SI  □  NO       
Se SI: tipizzazione dell’anca destra secondo Graf ____________________ (lista)  
tipizzazione dell’anca sinistra secondo Graf ____________________ (lista) Se NO:  
E’ stata prenotata?  □ SI  □  NO  
  
CONTESTO FAMIGLIARE  
  
117. I genitori fumano?  □ NO      
   □ Solo la madre  
   □ Solo il padre  
   □ Entrambi  
  
118. La madre, fuma la sigaretta elettronica?  □ SI  □  NO    
  
119. Il padre, fuma la sigaretta elettronica?  □ SI  □  NO    
  




121. Nelle ultime 2 settimane avete intenzionalmente fatto ascoltare musica al bambino? 
   □ SI  □  NO    
  
122. Il bambino frequenta l’asilo nido?  □ SI  □  NO    
  
123. Quanto spesso il bambino sta all’aria aperta?  □ Saltuariamente  
     □ meno di 1 ora al giorno  
     □ da 1 a 3 ore al giorno  
     □ oltre 3 ore al giorno  
  
124. Il bambino risiede in una via ad alto traffico*?    □ SI  □  NO    
  
125. Il bambino risiede in prossimità** di coltivazioni intensive***?  □ SI  □  NO    
  
  
Tooltip:   
*  Presenza di almeno 2 linee di autobus o passaggio di autocarri sulla strada dell’abitazione  
 
  
**  Se la distanza tra la casa e i campi è inferiore a 300 metri  
*** Grandi estensioni di terreno con piante tutte uguali trattate con sostanze chimiche  





126. Nel corso di questa visita al bambino è stato prescritto qualcosa?      □ SI    □  NO  
    
    
    
   Suggerito 
    
Se SI, specificare  □  Terapia farmacologica:  
  □   
    farmaco (ATC)  ………………………………………………….. +  
    motivo (ICD)  …………………………………………………….. + 
     
  □  Visita specialistica, specifica ………………………………………..…..  
  □    
  □  Esami di laboratorio   
 
185.  
  □    
  □  Esami diagnostici   
□ Ecografia, specificare sede  
 
  …………………………………………………  
□ Radiografia, specificare sede  
□  
  ………………………………………………  
□ Tac, specificare sede  
□  
  ……………………………………………………..……  
□ Risonanza, specificare sede  
□  
  …………………………………………………  □  
  □ Elettrocardiogramma    □  
  □ Elettroencefalogramma    □  
  □ Polisonnografia    
□ Altro, specificare  
□  




Appendix E. Data collected in the third visit  
T3   ̶    TERZA VISITA    




127. Data della  visita                     
   giorno  mese  anno  
    
  
CONTROLLO AUXOLOGICO   
  
VALUTAZIONE ANTROPOMETRICA                       
      
128. Peso (gr)       
129. Lunghezza (cm)      
130. Circonferenza cranica (cm)   





131. Il bambino è allattato al seno?   □ SI  □  NO     
Se SI, quante volte al giorno?      
Se NO, a che età è stato interrotto l’allattamento esclusivo al seno?       
(mesi)  
  
132. Il bambino è già stato svezzato?    □ SI  □  NO Se SI, specificare a quanti 
mesi      
  
133. Come viene svezzato/si intende svezzare il bambino?      □ Svezzamento 
classico per gradi    
     □ Autosvezzamento  
  




134. A casa, con chi mangia solitamente il bambino?   □ Mamma  
     □ Papà   
     □ Nonni   
    □ Altri famigliari  




□ Tata  
135. Il cibo che viene dato al bambino, solitamente è:      □ “Industriale” (pappe pronte)    
    
    
□ Preparato a casa  
136. Ci sono difficoltà nel proporre i cibi solidi?      □ Nessuna  
    □ Abbastanza  
    
  
□ Molta  
137. L’appetito del bambino è:     □ Scarso  
    □ Normale  
    
  
□ Eccessivo  
138. C’è preoccupazione riguardo la sua crescita?      
  
□ SI  □  NO    
139. Il bambino sta seguendo una dieta speciale?      □ SI  □  NO    
 Se SI, quale?    □ Vegetariana  
    □ Senza glutine  
    
lattosio  
□ A basso contenuto di  




140. Postura abituale nel sonno:  □ Prono  □ Supino    □ Di fianco      
  
141. La sera, dove si addormenta abitualmente?    □ Nel suo lettino  
      □ Nel lettone  
  
dove dorme    
  
   
    □ In una stanza diversa da quella  
142. Dove dorme abitualmente?    □ Tutta la notte nel suo lettino    
  □ Tutta la notte nel lettone   
  □ In entrambi ma in prevalenza nel suo lettino  
  
  
□ In entrambi ma in prevalenza nel lettone  
 
188.  
143. Dorme in camera da solo?     □ SI □  NO   
 Se NO; dorme in camera con fratelli?   □ SI □  NO   
  
144. Presenza di disturbi del sonno?  □ SI  □  NO  
   Se SI,  □ Difficoltà ad addormentarsi  
     □ Risvegli frequenti  
     □ Dorme poco  
     □ Altro, specificare ______________________  
  
   Se Risvegli frequenti:   
   Nell’ultima settimana quante volte si è svegliato in media per notte?     







   (campo di testo libero)  
     
145. Fontanella anteriore normale?  
____________________  
  
 □ SI  □  NO    Se NO, specificare:  
146. Cute normale?  
____________________  
  
□ SI  □  NO    Se NO, specificare:  
147. Orofaringe normale?   
____________________  
   
□ SI  □  NO    Se NO, specificare:  
148. Cuore normale? 
____________________  
  
□ SI  □  NO    Se NO, specificare:  
149. Torace normale?   
____________________  
  
□ SI  □  NO    Se NO, specificare:  
150. Addome normale?   
____________________  
  
□ SI  □  NO    Se NO, specificare:  
151. Ombelico nomale?    □ SI  □  NO    Se NO, specificare:  
____________________  
  
   
152. Apparato genitale normale?    
____________________  
□ SI  □  NO    Se NO, specificare:  




 Se SI, Il bambino presenta:  □ Incisivi inferiori    
      
□ Incisivi superiori  
   □ Incisivi lato inferiori  □ Incisivi lato superiori  
   □ 1° Molare inferiore  □ 1° Molare superiore  
   □ Canini inferiori    □ Canini superiori  
  
  
VALUTAZIONE DELLO SVILUPPO NEUROLOGICO E PSICOMOTORIO   
   
CONTROLLO DELLA VISTA  
       
    
154. Riflesso rosso normale?    □ SI  □  NO    Se NO, specificare:  
____________________  
155. Riflessi pupillari e corneali normali?    □ SI  □  NO    Se NO, specificare:  
____________________  
156. Movimenti oculari normali?    □ SI  □  NO    Se NO, specificare:  
____________________  
157. Strabismo?  □ SI  □  NO    
158. E’ stata fatta diagnosi di cataratta congenita?  □ SI  □  NO  
 
  
MOTRICITÀ      
      
 
    
   Patologico  
Normale  Da rivalutare a 
breve 
159. Si muove bene e in modo simmetrico   □   □   
   □       
(movimenti ricchi, variabili, fluidi, compreso mani e piedi)      
160. Controllo assiale capo e tronco   □   □   
  
 (seduto con appoggio)    
 □     
161. Spostamenti   □   □   
  
(si mette sul fianco, rotola, si sposta di lato facendo perno sull’ombelico)  
 □     
162. Manipolazione   □   □   
  
(afferra gli oggetti, sia con la destra che la sinistra, con presa globale e   
 □     
poi con pinza inferiore, li porta alla bocca)  
  
    




163. Qualità globale dell’attenzione   □   □   
   □     
(guarda e segue, si orienta verso i suoni, espressivo, interessato agli  
eventi famigliari, anticipa eventi conosciuti)  
164. Comportamento diversificato verso estranei   □   □   
  □     
e ambienti nuovi (inizio)  
165. Comunicazione verbale (vocalizzi, gorgheggi, inizio lallazione)   □   □   
  □     




PROCEDURE CLINICO-STRUMENTALI E TERAPEUTICHE  
  
167. Profilassi con Vitamina D in corso?  □ SI  □  NO    
□     
168. Altre supplementazioni (vitamine o integratori)?  □ SI  □  NO    
   Se SI,  □ Ferro  □ Fluoro  □ Altro, specificare ______________________  
169. Ecografia delle anche effettuata?  □ SI  □  NO     □ Ho già risposto nella II°  
visita   
Se SI,        tipizzazione dell’anca destra secondo Graf  ____________________ (lista)           
tipizzazione dell’anca sinistra secondo Graf ____________________ (lista)    
  
CONTESTO FAMIGLIARE  
  
170. La madre ha sofferto di depressione post-parto? □ SI  □  NO    
171. Il padre ha sofferto di depressione post-parto?   □ SI  □  NO    
172. I genitori fumano?  □  NO      
   □ Solo la madre  
  □ Solo il padre   □ Entrambi  
  




174. Il padre, fuma la sigaretta elettronica?  □ SI  □  NO    
  
175. Nelle ultime 2 settimane avete letto al bambino un libro ad alta voce? □ SI  □  NO    
 Se SI:  Qual’è il libro preferito dal bambino?  specificare  
___________________________________  
  
176. Nelle ultime 2 settimane avete intenzionalmente fatto ascoltare musica al bambino? 
   □ SI  □  NO    
177. Quando è sveglio, trascorre del tempo a pancia in giù (Tummy time)?  □ SI  □  NO    
 Se SI, per quanto tempo nell’arco della giornata?   □ meno di 15 minuti    
     □ da 15 a 30 minuti  
     □ da 30 minuti a 1 ora  
     □ oltre 1 ora  
  
Quando è sveglio e tranquillo dove passa la maggior parte del tempo?   
   □ per terra (su un tappeto o coperta)   
   □ nella sdraietta/seggiolina  
   □ in braccio ad un adulto  
   □ altro (palestrina, tappeto gioco, box, girello...)  
  
178. Il bambino frequenta l’asilo nido?  □ SI  □  NO    
  
179. Quanto spesso il bambino sta all’aria aperta?  □ Saltuariamente  
     □ meno di 1 ora al giorno  
     □ da 1 a 3 ore al giorno  




180. Nel corso di questa visita al bambino è stato prescritto qualcosa?      □ SI    □  NO  
    
    
    
   Suggerito 
    
Se SI, specificare  □  Terapia farmacologica:  
  □   
    farmaco (ATC)  ………………………………………………….. +  
    motivo (ICD)  …………………………………………………….. + 
 
192.  
     
  □  Visita specialistica, specifica ………………………………………..…..  
  □    
  □  Esami di laboratorio   
  □    
  □  Esami diagnostici   
□ Ecografia, specificare sede  
 
  …………………………………………………  
□ Radiografia, specificare sede  
□  
  ………………………………………………  
□ Tac, specificare sede  
□  
  ……………………………………………………..……  
□ Risonanza, specificare sede  
□  
  …………………………………………………  □  
□ Elettrocardiogramma    □  
□ Elettroencefalogramma    □  
□ Polisonnografia    
□ Altro, specificare  
□  
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